Quiver News

$70,000 of DAVITA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease. H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease."

You can find more data on corporate lobbying on Quiver Quantitative.

DVA Insider Trading Activity

DVA insiders have traded $DVA stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

• HATHAWAY INC BERKSHIRE has made 0 purchases and 19 sales selling 953,091 shares for an estimated $147,740,046.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DVA Hedge Fund Activity

We have seen 218 institutional investors add shares of DVA stock to their portfolio, and 315 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 607,396 shares (+409.9%) to their portfolio in Q4 2024, for an estimated $90,836,071
• BLACKROCK, INC. removed 465,288 shares (-9.9%) from their portfolio in Q4 2024, for an estimated $69,583,820
• BANK OF AMERICA CORP /DE/ removed 431,630 shares (-69.0%) from their portfolio in Q4 2024, for an estimated $64,550,266
• EPOCH INVESTMENT PARTNERS, INC. added 368,436 shares (+inf%) to their portfolio in Q4 2024, for an estimated $55,099,603
• JPMORGAN CHASE & CO removed 332,508 shares (-59.2%) from their portfolio in Q4 2024, for an estimated $49,726,571
• CITADEL ADVISORS LLC removed 332,336 shares (-76.6%) from their portfolio in Q4 2024, for an estimated $49,700,848
• HOLOCENE ADVISORS, LP added 302,154 shares (+inf%) to their portfolio in Q4 2024, for an estimated $45,187,130

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$110,000 of TRANSDIGM GROUP INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY 2026 National Defense Authorization Act and oversight of DoD contracts."

You can find more data on corporate lobbying on Quiver Quantitative.

TDG Congressional Stock Trading

Members of Congress have traded $TDG stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $TDG stock by members of Congress over the last 6 months:

• REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 02/04, 01/16, 10/17.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TDG Insider Trading Activity

TDG insiders have traded $TDG stock on the open market 277 times in the past 6 months. Of those trades, 0 have been purchases and 277 have been sales.

Here’s a breakdown of recent trading of $TDG stock by insiders over the last 6 months:

• ROBERT J SMALL has made 0 purchases and 60 sales selling 131,737 shares for an estimated $173,206,331.
• KEVIN M STEIN (President & CEO) has made 0 purchases and 69 sales selling 80,000 shares for an estimated $103,676,466.
• W NICHOLAS HOWLEY has made 0 purchases and 86 sales selling 32,832 shares for an estimated $43,288,565.
• JOEL REISS (Co-Chief Operating Officer) has made 0 purchases and 58 sales selling 18,000 shares for an estimated $23,863,035.
• JESSICA L WARREN (GC, CCO, Secretary) has made 0 purchases and 4 sales selling 275 shares for an estimated $378,487.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TDG Hedge Fund Activity

We have seen 491 institutional investors add shares of TDG stock to their portfolio, and 420 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PROFICIO CAPITAL PARTNERS LLC added 729,930 shares (+286247.1%) to their portfolio in Q4 2024, for an estimated $925,025,690
• EDGEWOOD MANAGEMENT LLC added 315,317 shares (+inf%) to their portfolio in Q4 2024, for an estimated $399,594,927
• JPMORGAN CHASE & CO added 206,822 shares (+10.4%) to their portfolio in Q4 2024, for an estimated $262,101,384
• PRINCIPAL FINANCIAL GROUP INC added 185,422 shares (+9.6%) to their portfolio in Q4 2024, for an estimated $234,981,592
• BLACKROCK, INC. added 166,202 shares (+4.2%) to their portfolio in Q4 2024, for an estimated $210,624,470
• MORGAN STANLEY added 163,071 shares (+12.8%) to their portfolio in Q4 2024, for an estimated $206,656,616
• GEODE CAPITAL MANAGEMENT, LLC added 159,839 shares (+14.1%) to their portfolio in Q4 2024, for an estimated $202,560,767

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TDG Analyst Ratings

Wall Street analysts have issued reports on $TDG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 03/25/2025
• KeyBanc issued a "Overweight" rating on 10/23/2024

To track analyst ratings and price targets for TDG, check out Quiver Quantitative's $TDG forecast page.

TDG Price Targets

Multiple analysts have issued price targets for $TDG recently. We have seen 2 analysts offer price targets for $TDG in the last 6 months, with a median target of $1464.0.

Here are some recent targets:

• Matthew Akers from Wells Fargo set a target price of $1580.0 on 03/25/2025
• Scott Deuschle from Deutsche Bank set a target price of $1348.0 on 01/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$70,000 of UL LLC D/B/A UL SOLUTIONS lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Lithium-ion battery safety."

You can find more data on corporate lobbying on Quiver Quantitative.

ULS Insider Trading Activity

ULS insiders have traded $ULS stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ULS stock by insiders over the last 6 months:

• GITTE SCHJOTZ (See Remarks) has made 0 purchases and 5 sales selling 31,325 shares for an estimated $1,619,764.
• ALBERTO UGGETTI (EVP & CCO) sold 1,938 shares for an estimated $102,714

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ULS Hedge Fund Activity

We have seen 111 institutional investors add shares of ULS stock to their portfolio, and 70 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,987,295 shares (+88.8%) to their portfolio in Q4 2024, for an estimated $99,126,274
• CITADEL ADVISORS LLC removed 1,311,106 shares (-84.3%) from their portfolio in Q4 2024, for an estimated $65,397,967
• ALYESKA INVESTMENT GROUP, L.P. removed 940,738 shares (-57.2%) from their portfolio in Q4 2024, for an estimated $46,924,011
• NORGES BANK added 939,104 shares (+36.9%) to their portfolio in Q4 2024, for an estimated $46,842,507
• CAPITAL INTERNATIONAL INVESTORS added 809,779 shares (+7.4%) to their portfolio in Q4 2024, for an estimated $40,391,776
• MARSHALL WACE, LLP removed 766,097 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $38,212,918
• BALYASNY ASSET MANAGEMENT L.P. removed 686,639 shares (-67.9%) from their portfolio in Q4 2024, for an estimated $34,249,553

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ULS Analyst Ratings

Wall Street analysts have issued reports on $ULS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 10/22/2024

To track analyst ratings and price targets for ULS, check out Quiver Quantitative's $ULS forecast page.

ULS Price Targets

Multiple analysts have issued price targets for $ULS recently. We have seen 2 analysts offer price targets for $ULS in the last 6 months, with a median target of $56.5.

Here are some recent targets:

• George Tong from Goldman Sachs set a target price of $51.0 on 11/06/2024
• Stephanie Moore from Jefferies set a target price of $62.0 on 10/22/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$AIM ($AIM) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $101,000 and earnings of -$0.12 per share.

You can see Quiver Quantitative's $AIM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

$AIM Insider Trading Activity

$AIM insiders have traded $AIM stock on the open market 12 times in the past 6 months. Of those trades, 11 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $AIM stock by insiders over the last 6 months:

• THOMAS K EQUELS (CEO & President) has made 7 purchases buying 365,171 shares for an estimated $58,626 and 0 sales.
• STEWART APPELROUTH has made 3 purchases buying 93,065 shares for an estimated $18,172 and 0 sales.
• WILLIAM M MITCHELL sold 4,580 shares for an estimated $883
• PETER W III RODINO (COO, Secretary, Gen. Counsel) purchased 500 shares for an estimated $43

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AIM Hedge Fund Activity

We have seen 11 institutional investors add shares of $AIM stock to their portfolio, and 10 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ARMISTICE CAPITAL, LLC removed 4,330,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $857,340
• CITADEL ADVISORS LLC removed 98,780 shares (-21.6%) from their portfolio in Q4 2024, for an estimated $19,558
• TWO SIGMA SECURITIES, LLC added 71,305 shares (+inf%) to their portfolio in Q4 2024, for an estimated $14,118
• VIRTU FINANCIAL LLC removed 65,471 shares (-64.1%) from their portfolio in Q4 2024, for an estimated $12,963
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 38,040 shares (+inf%) to their portfolio in Q4 2024, for an estimated $7,531
• VERITION FUND MANAGEMENT LLC added 18,000 shares (+11.8%) to their portfolio in Q4 2024, for an estimated $3,564
• RENAISSANCE TECHNOLOGIES LLC added 17,271 shares (+7.1%) to their portfolio in Q4 2024, for an estimated $3,419

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

COCRYSTAL PHARMA ($COCP) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.54 per share.

You can see Quiver Quantitative's $COCP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

COCRYSTAL PHARMA Hedge Fund Activity

We have seen 8 institutional investors add shares of COCRYSTAL PHARMA stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 25,673 shares (-67.9%) from their portfolio in Q4 2024, for an estimated $51,859
• VELAN CAPITAL INVESTMENT MANAGEMENT LP added 10,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,200
• UBS GROUP AG added 5,220 shares (+573.6%) to their portfolio in Q4 2024, for an estimated $10,544
• MORGAN STANLEY added 5,046 shares (+8.5%) to their portfolio in Q4 2024, for an estimated $10,192
• RENAISSANCE TECHNOLOGIES LLC removed 4,200 shares (-3.2%) from their portfolio in Q4 2024, for an estimated $8,484
• GEODE CAPITAL MANAGEMENT, LLC added 2,630 shares (+4.0%) to their portfolio in Q4 2024, for an estimated $5,312
• TOWER RESEARCH CAPITAL LLC (TRC) removed 1,913 shares (-69.7%) from their portfolio in Q4 2024, for an estimated $3,864

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$BSEM ($BSEM) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $88,418,700 and earnings of $0.38 per share.

You can see Quiver Quantitative's $BSEM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$LGL ($LGL) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $505,000 and earnings of $0.06 per share.

You can see Quiver Quantitative's $LGL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

$LGL Hedge Fund Activity

We have seen 5 institutional investors add shares of $LGL stock to their portfolio, and 8 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMCO INVESTORS, INC. ET AL added 67,252 shares (+14.1%) to their portfolio in Q4 2024, for an estimated $401,494
• BARD ASSOCIATES INC added 8,098 shares (+1.5%) to their portfolio in Q4 2024, for an estimated $48,345
• RENAISSANCE TECHNOLOGIES LLC removed 5,900 shares (-3.3%) from their portfolio in Q4 2024, for an estimated $35,223
• CALDWELL SUTTER CAPITAL, INC. removed 3,256 shares (-3.1%) from their portfolio in Q4 2024, for an estimated $19,438
• VANGUARD GROUP INC removed 3,225 shares (-3.0%) from their portfolio in Q4 2024, for an estimated $19,253
• UBS GROUP AG removed 745 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,447
• DIMENSIONAL FUND ADVISORS LP added 502 shares (+0.5%) to their portfolio in Q4 2024, for an estimated $2,996

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$MYNZ ($MYNZ) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $306,000 and earnings of -$3.67 per share.

You can see Quiver Quantitative's $MYNZ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

$MYNZ Hedge Fund Activity

We have seen 1 institutional investors add shares of $MYNZ stock to their portfolio, and 7 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 3,762 shares (+inf%) to their portfolio in Q4 2024, for an estimated $16,251
• NORTHERN TRUST CORP removed 748 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $3,231
• TWO SIGMA SECURITIES, LLC removed 588 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,540
• JANE STREET GROUP, LLC removed 364 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,572
• XTX TOPCO LTD removed 299 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,291
• FMR LLC removed 46 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $198
• CITIGROUP INC removed 17 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $73

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$RNTX ($RNTX) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.49 per share.

You can see Quiver Quantitative's $RNTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

LEVI STRAUSS ($LEVI) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $1,572,327,623 and earnings of $0.29 per share.

You can see Quiver Quantitative's $LEVI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

LEVI STRAUSS Insider Trading Activity

LEVI STRAUSS insiders have traded $LEVI stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $LEVI stock by insiders over the last 6 months:

• DAVID A FRIEDMAN has made 0 purchases and 3 sales selling 16,664 shares for an estimated $301,785.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LEVI STRAUSS Hedge Fund Activity

We have seen 121 institutional investors add shares of LEVI STRAUSS stock to their portfolio, and 101 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MACQUARIE GROUP LTD removed 5,720,775 shares (-76.1%) from their portfolio in Q4 2024, for an estimated $98,969,407
• FMR LLC removed 1,841,896 shares (-19.6%) from their portfolio in Q4 2024, for an estimated $31,864,800
• MILLENNIUM MANAGEMENT LLC added 1,598,523 shares (+560.0%) to their portfolio in Q4 2024, for an estimated $27,654,447
• BALYASNY ASSET MANAGEMENT L.P. removed 1,471,447 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $25,456,033
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,310,748 shares (+1079.9%) to their portfolio in Q4 2024, for an estimated $22,675,940
• ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 840,251 shares (+119.8%) to their portfolio in Q4 2024, for an estimated $14,536,342
• CEREDEX VALUE ADVISORS LLC added 815,950 shares (+164.4%) to their portfolio in Q4 2024, for an estimated $14,115,935

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LEVI STRAUSS Analyst Ratings

Wall Street analysts have issued reports on $LEVI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 02/03/2025

To track analyst ratings and price targets for LEVI STRAUSS, check out Quiver Quantitative's $LEVI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

GREENBRIERS (THE ($GBX) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $907,515,300 and earnings of $1.80 per share.

You can see Quiver Quantitative's $GBX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

GREENBRIERS (THE Insider Trading Activity

GREENBRIERS (THE insiders have traded $GBX stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $GBX stock by insiders over the last 6 months:

• BRIAN J COMSTOCK (EVP & President, The Americas) has made 0 purchases and 3 sales selling 55,000 shares for an estimated $3,490,893.
• WILLIAM J. KRUEGER (SVP, COO, The Americas) has made 0 purchases and 11 sales selling 12,389 shares for an estimated $763,860.
• RICARDO GALVAN (SVP, Operations, Maint Svcs.) has made 0 purchases and 3 sales selling 8,314 shares for an estimated $522,414.
• MARTIN RAYMOND BAKER (Senior Vice President) sold 8,285 shares for an estimated $517,771

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GREENBRIERS (THE Hedge Fund Activity

We have seen 122 institutional investors add shares of GREENBRIERS (THE stock to their portfolio, and 111 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• LSV ASSET MANAGEMENT added 264,552 shares (+94.3%) to their portfolio in Q4 2024, for an estimated $16,135,026
• UBS GROUP AG added 221,447 shares (+776.7%) to their portfolio in Q4 2024, for an estimated $13,506,052
• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 204,020 shares (-27.4%) from their portfolio in Q4 2024, for an estimated $12,443,179
• ENCOMPASS CAPITAL ADVISORS LLC added 193,340 shares (+26.2%) to their portfolio in Q4 2024, for an estimated $11,791,806
• GOLDMAN SACHS GROUP INC added 172,367 shares (+68.1%) to their portfolio in Q4 2024, for an estimated $10,512,663
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 158,568 shares (+inf%) to their portfolio in Q4 2024, for an estimated $9,671,062
• BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 136,424 shares (-8.5%) from their portfolio in Q4 2024, for an estimated $8,320,499

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GREENBRIERS (THE Analyst Ratings

Wall Street analysts have issued reports on $GBX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Stephens issued a "Overweight" rating on 04/04/2025
• Susquehanna issued a "Positive" rating on 01/09/2025

To track analyst ratings and price targets for GREENBRIERS (THE, check out Quiver Quantitative's $GBX forecast page.

GREENBRIERS (THE Price Targets

Multiple analysts have issued price targets for $GBX recently. We have seen 2 analysts offer price targets for $GBX in the last 6 months, with a median target of $68.5.

Here are some recent targets:

• Ken Hoexter from Lake Street set a target price of $62.0 on 04/04/2025
• Bascome Majors from Susquehanna set a target price of $75.0 on 01/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$60,000 of AXON ENTERPRISE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 3269, the Law Enforcement Innovate to De-Escalate Act. H.R. 3269, the Law Enforcement Innovate to De-Escalate Act. H.R. 3269, the Law Enforcement Innovate to De-Escalate Act."

You can find more data on corporate lobbying on Quiver Quantitative.

AXON Congressional Stock Trading

Members of Congress have traded $AXON stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $AXON stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.
• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 12/18.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AXON Insider Trading Activity

AXON insiders have traded $AXON stock on the open market 97 times in the past 6 months. Of those trades, 0 have been purchases and 97 have been sales.

Here’s a breakdown of recent trading of $AXON stock by insiders over the last 6 months:

• JEFFREY C KUNINS (CPO & CTO) has made 0 purchases and 35 sales selling 48,710 shares for an estimated $29,522,406.
• JOSHUA ISNER (PRESIDENT) has made 0 purchases and 31 sales selling 33,985 shares for an estimated $21,068,443.
• BRITTANY BAGLEY (COO & CFO) has made 0 purchases and 6 sales selling 9,825 shares for an estimated $6,027,070.
• MICHAEL GARNREITER has made 0 purchases and 14 sales selling 3,000 shares for an estimated $1,677,196.
• JULIE A CULLIVAN sold 1,261 shares for an estimated $860,077
• MATTHEW R MCBRADY has made 0 purchases and 8 sales selling 1,000 shares for an estimated $605,195.
• CAITLIN ELIZABETH KALINOWSKI sold 450 shares for an estimated $271,831
• JERI WILLIAMS sold 307 shares for an estimated $169,685

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AXON Hedge Fund Activity

We have seen 513 institutional investors add shares of AXON stock to their portfolio, and 381 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL INTERNATIONAL INVESTORS removed 1,207,000 shares (-92.2%) from their portfolio in Q4 2024, for an estimated $717,344,240
• CAPITAL WORLD INVESTORS added 841,772 shares (+86.4%) to their portfolio in Q4 2024, for an estimated $500,281,935
• ALLIANCEBERNSTEIN L.P. added 812,337 shares (+273.8%) to their portfolio in Q4 2024, for an estimated $482,788,125
• GQG PARTNERS LLC added 804,867 shares (+inf%) to their portfolio in Q4 2024, for an estimated $478,348,555
• WELLINGTON MANAGEMENT GROUP LLP removed 694,808 shares (-63.6%) from their portfolio in Q4 2024, for an estimated $412,938,290
• BLACKROCK, INC. removed 521,707 shares (-6.6%) from their portfolio in Q4 2024, for an estimated $310,060,904
• CHAMPLAIN INVESTMENT PARTNERS, LLC removed 509,435 shares (-74.7%) from their portfolio in Q4 2024, for an estimated $302,767,409

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXON Analyst Ratings

Wall Street analysts have issued reports on $AXON in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JMP Securities issued a "Outperform" rating on 02/04/2025
• Needham issued a "Buy" rating on 10/22/2024
• Goldman Sachs issued a "Buy" rating on 10/22/2024

To track analyst ratings and price targets for AXON, check out Quiver Quantitative's $AXON forecast page.

AXON Price Targets

Multiple analysts have issued price targets for $AXON recently. We have seen 4 analysts offer price targets for $AXON in the last 6 months, with a median target of $612.5.

Here are some recent targets:

• An analyst from Barclays set a target price of $726.0 on 02/27/2025
• Meta Marshall from Morgan Stanley set a target price of $700.0 on 12/03/2024
• Joshua Reilly from Needham set a target price of $525.0 on 10/22/2024
• Michael Ng from Goldman Sachs set a target price of $441.0 on 10/22/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of POLARIS INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Army & USMC Research, Development, Test and Evaluation(RDT&E)"

You can find more data on corporate lobbying on Quiver Quantitative.

PII Hedge Fund Activity

We have seen 218 institutional investors add shares of PII stock to their portfolio, and 205 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SELECT EQUITY GROUP, L.P. removed 1,271,919 shares (-65.5%) from their portfolio in Q4 2024, for an estimated $73,287,972
• JPMORGAN CHASE & CO removed 1,163,637 shares (-90.7%) from their portfolio in Q4 2024, for an estimated $67,048,763
• RWWM, INC. added 703,322 shares (+377.4%) to their portfolio in Q4 2024, for an estimated $40,525,413
• ARTISAN PARTNERS LIMITED PARTNERSHIP added 513,542 shares (+132.6%) to their portfolio in Q4 2024, for an estimated $29,590,290
• AUTO-OWNERS INSURANCE CO added 400,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $23,048,000
• CAPITAL WORLD INVESTORS added 388,050 shares (+6.7%) to their portfolio in Q4 2024, for an estimated $22,359,441
• NORGES BANK added 350,000 shares (+449.0%) to their portfolio in Q4 2024, for an estimated $20,167,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PII Analyst Ratings

Wall Street analysts have issued reports on $PII in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• KeyBanc issued a "Overweight" rating on 10/23/2024

To track analyst ratings and price targets for PII, check out Quiver Quantitative's $PII forecast page.

PII Price Targets

Multiple analysts have issued price targets for $PII recently. We have seen 5 analysts offer price targets for $PII in the last 6 months, with a median target of $80.0.

Here are some recent targets:

• Brandon Rolle from D.A. Davidson set a target price of $84.0 on 10/24/2024
• Noah Zatzkin from KeyBanc set a target price of $80.0 on 10/23/2024
• Joseph Spak from RBC Capital set a target price of $73.0 on 10/23/2024
• Craig Kennison from Robert W. Baird set a target price of $84.0 on 10/23/2024
• James Hardiman from Citigroup set a target price of $73.0 on 10/23/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of BIGBEAR.AI lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Education on artificial intelligence capabilities."

You can find more data on corporate lobbying on Quiver Quantitative.

BBAI Insider Trading Activity

BBAI insiders have traded $BBAI stock on the open market 59 times in the past 6 months. Of those trades, 0 have been purchases and 59 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by insiders over the last 6 months:

• ULTIMATE HOLDINGS, LLC BBAI has made 0 purchases and 39 sales selling 80,128,293 shares for an estimated $235,918,429.
• ULTIMATE HOLDINGS, LLC PANGIAM has made 0 purchases and 11 sales selling 36,551,743 shares for an estimated $147,532,223.
• AMANDA LONG (Chief Executive Officer) has made 0 purchases and 3 sales selling 466,140 shares for an estimated $1,997,630.
• SEAN RAYMOND RICKER (Chief Accounting Officer) has made 0 purchases and 4 sales selling 83,618 shares for an estimated $268,810.
• SEAN BERNARD BATTLE sold 44,813 shares for an estimated $199,865
• DOROTHY D HAYES sold 16,000 shares for an estimated $52,640

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BBAI Hedge Fund Activity

We have seen 94 institutional investors add shares of BBAI stock to their portfolio, and 33 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 3,778,835 shares (+2712.1%) to their portfolio in Q4 2024, for an estimated $16,815,815
• MILLENNIUM MANAGEMENT LLC added 2,898,491 shares (+inf%) to their portfolio in Q4 2024, for an estimated $12,898,284
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,014,902 shares (+143.4%) to their portfolio in Q4 2024, for an estimated $4,516,313
• BLACKROCK, INC. added 1,012,457 shares (+13.5%) to their portfolio in Q4 2024, for an estimated $4,505,433
• HRT FINANCIAL LP added 945,649 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,208,138
• TFG ASSET MANAGEMENT GP LTD added 900,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,005,000
• SOVIERO ASSET MANAGEMENT, LP added 730,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $3,248,500

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BBAI Analyst Ratings

Wall Street analysts have issued reports on $BBAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• H.C. Wainwright issued a "Buy" rating on 12/30/2024

To track analyst ratings and price targets for BBAI, check out Quiver Quantitative's $BBAI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of QUEST DIAGNOSTICS INCORPORATED lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. Policies, rules and regulations related to clinical laboratories and Medicare coverage policies. H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Issues related to Medicaid policies impacting oral health care. Policies, rules and regulations related to Medicare coverage of clinical laboratories and their services."

You can find more data on corporate lobbying on Quiver Quantitative.

DGX Insider Trading Activity

DGX insiders have traded $DGX stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.

Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:

• CATHERINE T. DOHERTY (EVP, Regional Businesses) has made 0 purchases and 7 sales selling 41,447 shares for an estimated $6,843,173.
• MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 6 sales selling 41,513 shares for an estimated $6,819,095.
• J. E. DAVIS (CEO and President) has made 0 purchases and 15 sales selling 39,191 shares for an estimated $6,602,074.
• MICHAEL J DEPPE (SVP, Corp. Controller & CAO) has made 0 purchases and 6 sales selling 18,755 shares for an estimated $2,889,122.
• KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 2 sales selling 4,330 shares for an estimated $712,875.
• VICKY B GREGG sold 1,250 shares for an estimated $205,710
• MARK E DELANEY (SVP & Chief Commercial Officer) sold 403 shares for an estimated $66,214
• PATRICK PLEWMAN (SVP for Diagnostic Services) sold 320 shares for an estimated $54,307

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DGX Hedge Fund Activity

We have seen 366 institutional investors add shares of DGX stock to their portfolio, and 348 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 1,637,525 shares (+42.5%) to their portfolio in Q4 2024, for an estimated $247,037,021
• JPMORGAN CHASE & CO added 916,898 shares (+60.4%) to their portfolio in Q4 2024, for an estimated $138,323,232
• AMERICAN CENTURY COMPANIES INC removed 764,962 shares (-33.4%) from their portfolio in Q4 2024, for an estimated $115,402,167
• CITADEL ADVISORS LLC removed 748,133 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $112,863,344
• UBS GROUP AG added 588,478 shares (+156.3%) to their portfolio in Q4 2024, for an estimated $88,777,791
• WELLINGTON MANAGEMENT GROUP LLP removed 549,280 shares (-23.5%) from their portfolio in Q4 2024, for an estimated $82,864,380
• ALLIANCEBERNSTEIN L.P. added 497,995 shares (+83.7%) to their portfolio in Q4 2024, for an estimated $75,127,525

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DGX Price Targets

Multiple analysts have issued price targets for $DGX recently. We have seen 7 analysts offer price targets for $DGX in the last 6 months, with a median target of $180.0.

Here are some recent targets:

• David Westenberg from Piper Sandler set a target price of $180.0 on 02/03/2025
• David MacDonald from Truist Financial set a target price of $182.0 on 01/31/2025
• Eric Coldwell from Robert W. Baird set a target price of $189.0 on 01/31/2025
• Patrick Donnelly from Citigroup set a target price of $185.0 on 10/23/2024
• Michael Cherny from Leerink Partners set a target price of $165.0 on 10/23/2024
• Stephanie Davis from Barclays set a target price of $168.0 on 10/23/2024
• Paige Meyer from CFRA set a target price of $178.0 on 10/22/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of FLUOR CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to energy and transportation"

You can find more data on corporate lobbying on Quiver Quantitative.

FLR Insider Trading Activity

FLR insiders have traded $FLR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $FLR stock by insiders over the last 6 months:

• MARK E FIELDS (GROUP PRESIDENT) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $2,831,268.
• JOSEPH L BRENNAN (EVP, CHIEF FINANCIAL OFFICER) sold 11,619 shares for an estimated $584,400
• THOMAS P D'AGOSTINO (GROUP PRESIDENT) sold 7,681 shares for an estimated $433,139

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FLR Hedge Fund Activity

We have seen 223 institutional investors add shares of FLR stock to their portfolio, and 183 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 2,722,107 shares (-20.6%) from their portfolio in Q4 2024, for an estimated $134,254,317
• CITADEL ADVISORS LLC added 1,694,945 shares (+117.3%) to their portfolio in Q4 2024, for an estimated $83,594,687
• ALYESKA INVESTMENT GROUP, L.P. added 1,523,647 shares (+329.5%) to their portfolio in Q4 2024, for an estimated $75,146,270
• RUBRIC CAPITAL MANAGEMENT LP removed 1,458,441 shares (-52.4%) from their portfolio in Q4 2024, for an estimated $71,930,310
• THRIVENT FINANCIAL FOR LUTHERANS removed 1,272,674 shares (-63.5%) from their portfolio in Q4 2024, for an estimated $62,768,281
• CARTENNA CAPITAL, LP removed 1,265,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $62,389,800
• BALYASNY ASSET MANAGEMENT L.P. added 1,046,610 shares (+10125.9%) to their portfolio in Q4 2024, for an estimated $51,618,805

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FLR Analyst Ratings

Wall Street analysts have issued reports on $FLR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• KeyBanc issued a "Overweight" rating on 01/08/2025
• Citigroup issued a "Buy" rating on 12/03/2024

To track analyst ratings and price targets for FLR, check out Quiver Quantitative's $FLR forecast page.

FLR Price Targets

Multiple analysts have issued price targets for $FLR recently. We have seen 4 analysts offer price targets for $FLR in the last 6 months, with a median target of $61.5.

Here are some recent targets:

• An analyst from Barclays set a target price of $40.0 on 02/27/2025
• Andrew Wittmann from Robert W. Baird set a target price of $58.0 on 12/18/2024
• Andrew Kaplowitz from Citigroup set a target price of $65.0 on 10/22/2024
• Jamie Cook from Truist Financial set a target price of $66.0 on 10/09/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of INTERDIGITAL lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues impacting infringement on US patents"

You can find more data on corporate lobbying on Quiver Quantitative.

IDCC Insider Trading Activity

IDCC insiders have traded $IDCC stock on the open market 86 times in the past 6 months. Of those trades, 0 have been purchases and 86 have been sales.

Here’s a breakdown of recent trading of $IDCC stock by insiders over the last 6 months:

• LAWRENCE LIREN CHEN (President and CEO) has made 0 purchases and 44 sales selling 111,782 shares for an estimated $23,097,296.
• RICHARD BREZSKI (Chief Financial Officer) has made 0 purchases and 14 sales selling 31,530 shares for an estimated $6,757,299.
• STEWART D HUTCHESON has made 0 purchases and 8 sales selling 8,398 shares for an estimated $1,797,393.
• EEVA K. HAKORANTA (Chief Licensing Officer) has made 0 purchases and 4 sales selling 5,150 shares for an estimated $1,121,107.
• RAJESH PANKAJ (Chief Technology Officer) has made 0 purchases and 6 sales selling 4,200 shares for an estimated $780,262.
• JEAN F RANKIN has made 0 purchases and 6 sales selling 2,679 shares for an estimated $597,380.
• JOSHUA D. SCHMIDT (CLO & Corp Secretary) has made 0 purchases and 4 sales selling 1,921 shares for an estimated $413,768.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IDCC Hedge Fund Activity

We have seen 209 institutional investors add shares of IDCC stock to their portfolio, and 188 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PACER ADVISORS, INC. removed 630,870 shares (-99.9%) from their portfolio in Q4 2024, for an estimated $122,212,136
• BARCLAYS PLC removed 599,098 shares (-88.6%) from their portfolio in Q4 2024, for an estimated $116,057,264
• CONGRESS ASSET MANAGEMENT CO added 323,061 shares (+inf%) to their portfolio in Q4 2024, for an estimated $62,583,376
• PRICE T ROWE ASSOCIATES INC /MD/ added 280,030 shares (+1451.2%) to their portfolio in Q4 2024, for an estimated $54,247,411
• AMERICAN CENTURY COMPANIES INC removed 238,936 shares (-36.0%) from their portfolio in Q4 2024, for an estimated $46,286,681
• JANE STREET GROUP, LLC removed 228,215 shares (-87.9%) from their portfolio in Q4 2024, for an estimated $44,209,809
• BOSTON TRUST WALDEN CORP removed 222,147 shares (-44.5%) from their portfolio in Q4 2024, for an estimated $43,034,316

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of NEWS CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues regarding artificial intelligence policy Issues related to competition in the technology sector"

You can find more data on corporate lobbying on Quiver Quantitative.

NWSA Hedge Fund Activity

We have seen 224 institutional investors add shares of NWSA stock to their portfolio, and 239 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BARCLAYS PLC removed 4,620,174 shares (-31.4%) from their portfolio in Q4 2024, for an estimated $127,239,591
• DEUTSCHE BANK AG\ added 3,678,215 shares (+291.2%) to their portfolio in Q4 2024, for an estimated $101,298,041
• YACKTMAN ASSET MANAGEMENT LP removed 2,885,358 shares (-23.7%) from their portfolio in Q4 2024, for an estimated $79,462,759
• INDEPENDENT FRANCHISE PARTNERS LLP added 2,812,080 shares (+11.8%) to their portfolio in Q4 2024, for an estimated $77,444,683
• 59 NORTH CAPITAL MANAGEMENT, LP added 2,569,343 shares (+40.2%) to their portfolio in Q4 2024, for an estimated $70,759,706
• METROPOLIS CAPITAL LTD removed 2,337,279 shares (-34.5%) from their portfolio in Q4 2024, for an estimated $64,368,663
• ASSENAGON ASSET MANAGEMENT S.A. added 1,704,944 shares (+374.6%) to their portfolio in Q4 2024, for an estimated $46,954,157

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NWSA Analyst Ratings

Wall Street analysts have issued reports on $NWSA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 02/04/2025
• Citigroup issued a "Buy" rating on 01/10/2025

To track analyst ratings and price targets for NWSA, check out Quiver Quantitative's $NWSA forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$22,500 of TERADYNE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Trade and export controls"

You can find more data on corporate lobbying on Quiver Quantitative.

TER Congressional Stock Trading

Members of Congress have traded $TER stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TER stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 02/12.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TER Insider Trading Activity

TER insiders have traded $TER stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $TER stock by insiders over the last 6 months:

• SANJAY MEHTA (VP and Chief Financial Officer) has made 0 purchases and 4 sales selling 9,125 shares for an estimated $1,088,562.
• GREGORY STEPHEN SMITH (President and CEO) has made 0 purchases and 2 sales selling 6,160 shares for an estimated $800,800.
• MERCEDES JOHNSON has made 0 purchases and 5 sales selling 3,125 shares for an estimated $357,350.
• RICHARD JOHN BURNS (President, Semiconductor Test) has made 0 purchases and 3 sales selling 2,329 shares for an estimated $280,183.
• RYAN DRISCOLL (VP, General Counsel, Secretary) has made 0 purchases and 4 sales selling 836 shares for an estimated $90,890.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TER Hedge Fund Activity

We have seen 342 institutional investors add shares of TER stock to their portfolio, and 351 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 3,750,102 shares (-24.4%) from their portfolio in Q4 2024, for an estimated $472,212,843
• VAN ECK ASSOCIATES CORP added 1,846,079 shares (+59.9%) to their portfolio in Q4 2024, for an estimated $232,458,267
• JPMORGAN CHASE & CO removed 1,800,535 shares (-26.8%) from their portfolio in Q4 2024, for an estimated $226,723,367
• KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 1,619,556 shares (-34.4%) from their portfolio in Q4 2024, for an estimated $203,934,491
• BOSTON PARTNERS removed 1,371,305 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $172,674,725
• NUVEEN ASSET MANAGEMENT, LLC removed 1,323,921 shares (-73.3%) from their portfolio in Q4 2024, for an estimated $166,708,132
• AMERIPRISE FINANCIAL INC added 1,065,474 shares (+28.3%) to their portfolio in Q4 2024, for an estimated $134,164,486

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TER Analyst Ratings

Wall Street analysts have issued reports on $TER in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 03/12/2025
• Vertical Research issued a "Buy" rating on 03/07/2025
• Cantor Fitzgerald issued a "Overweight" rating on 01/31/2025
• Susquehanna issued a "Positive" rating on 01/22/2025

To track analyst ratings and price targets for TER, check out Quiver Quantitative's $TER forecast page.

TER Price Targets

Multiple analysts have issued price targets for $TER recently. We have seen 5 analysts offer price targets for $TER in the last 6 months, with a median target of $130.0.

Here are some recent targets:

• An analyst from Morgan Stanley set a target price of $81.0 on 03/14/2025
• Timothy Arcuri from UBS set a target price of $130.0 on 03/12/2025
• Brian Chin from Stifel Nicolaus set a target price of $110.0 on 03/12/2025
• An analyst from Vertical Research set a target price of $135.0 on 03/07/2025
• Mehdi Hosseini from Susquehanna set a target price of $165.0 on 01/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of ORACLE lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to health information technology, privacy and cyber security; Issues related to Electronic Health Records Management (EHRM) and VA contract MilCon/VA Appropriations for Electronic Health Record Modernization (lets keep this one)"

You can find more data on corporate lobbying on Quiver Quantitative.

ORCL Congressional Stock Trading

Members of Congress have traded $ORCL stock 8 times in the past 6 months. Of those trades, 2 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/27, 02/14.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 01/28, 01/22, 01/21, 12/18.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ORCL Insider Trading Activity

ORCL insiders have traded $ORCL stock on the open market 13 times in the past 6 months. Of those trades, 1 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:

• SAFRA CATZ (Chief Executive Officer) has made 0 purchases and 11 sales selling 3,805,082 shares for an estimated $705,455,414.
• CHARLES W MOORMAN purchased 5,500 shares for an estimated $947,913
• NAOMI O SELIGMAN sold 2,000 shares for an estimated $291,620

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ORCL Hedge Fund Activity

We have seen 1,418 institutional investors add shares of ORCL stock to their portfolio, and 1,242 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PARNASSUS INVESTMENTS, LLC removed 3,704,750 shares (-51.9%) from their portfolio in Q4 2024, for an estimated $617,359,540
• JPMORGAN CHASE & CO added 3,480,225 shares (+8.3%) to their portfolio in Q4 2024, for an estimated $579,944,694
• BLACKROCK, INC. added 3,440,984 shares (+2.6%) to their portfolio in Q4 2024, for an estimated $573,405,573
• LEGAL & GENERAL GROUP PLC removed 3,431,858 shares (-24.0%) from their portfolio in Q4 2024, for an estimated $571,884,817
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 2,487,733 shares (-48.0%) from their portfolio in Q4 2024, for an estimated $414,555,827
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,350,448 shares (+20.5%) to their portfolio in Q4 2024, for an estimated $391,678,654
• VANGUARD GROUP INC added 2,296,069 shares (+1.5%) to their portfolio in Q4 2024, for an estimated $382,616,938

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ORCL Analyst Ratings

Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 03/11/2025
• Cantor Fitzgerald issued a "Overweight" rating on 02/10/2025
• Monness issued a "Sell" rating on 12/20/2024
• Piper Sandler issued a "Overweight" rating on 12/10/2024
• Jefferies issued a "Buy" rating on 12/09/2024
• JMP Securities issued a "Market Outperform" rating on 12/09/2024
• Bernstein issued a "Outperform" rating on 12/09/2024

To track analyst ratings and price targets for ORCL, check out Quiver Quantitative's $ORCL forecast page.

ORCL Price Targets

Multiple analysts have issued price targets for $ORCL recently. We have seen 6 analysts offer price targets for $ORCL in the last 6 months, with a median target of $201.0.

Here are some recent targets:

• Rishi Jaluria from RBC Capital set a target price of $145.0 on 03/11/2025
• Raimo Lenschow from Barclays set a target price of $202.0 on 03/11/2025
• Brian White from Monness set a target price of $130.0 on 12/20/2024
• Joseph Bonner from Argus Research set a target price of $200.0 on 12/11/2024
• Karl Keirstead from UBS set a target price of $210.0 on 12/10/2024
• John DiFucci from Guggenheim set a target price of $220.0 on 12/05/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of BLACKROCK FUNDS SERVICES GROUP LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to the financial services and asset management industry. Issues related to the Federal Energy Regulatory Commission (FERC) General issues regarding permitted reform Issues impacting retirement security, generally"

You can find more data on corporate lobbying on Quiver Quantitative.

BLK Congressional Stock Trading

Members of Congress have traded $BLK stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $BLK stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 02/24.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 02/24.
• REPRESENTATIVE GREG LANDSMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/19 and 1 sale worth up to $15,000 on 02/18.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 01/17.
• REPRESENTATIVE JAMES COMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/02 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BLK Insider Trading Activity

BLK insiders have traded $BLK stock on the open market 37 times in the past 6 months. Of those trades, 0 have been purchases and 37 have been sales.

Here’s a breakdown of recent trading of $BLK stock by insiders over the last 6 months:

• ROBERT L. GOLDSTEIN (Chief Operating Officer) has made 0 purchases and 10 sales selling 54,000 shares for an estimated $56,485,636.
• LAURENCE FINK (Chairman and CEO) has made 0 purchases and 6 sales selling 48,700 shares for an estimated $50,441,710.
• MARK WIEDMAN (Senior Managing Director) has made 0 purchases and 7 sales selling 36,190 shares for an estimated $37,851,104.
• J. RICHARD KUSHEL (Senior Managing Director) has made 0 purchases and 5 sales selling 20,430 shares for an estimated $21,234,593.
• CHRISTOPHER J. MEADE (General Counsel and CLO) has made 0 purchases and 9 sales selling 18,000 shares for an estimated $18,824,988.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BLK Hedge Fund Activity

We have seen 51 institutional investors add shares of BLK stock to their portfolio, and 1,500 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC removed 13,308,201 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $13,642,369,927
• BLACKROCK, INC. removed 9,629,693 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $9,871,494,591
• STATE STREET CORP removed 5,983,583 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $6,133,830,769
• BANK OF AMERICA CORP /DE/ removed 5,258,248 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $5,390,282,607
• TEMASEK HOLDINGS (PRIVATE) LTD removed 5,092,825 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $5,220,705,835
• CAPITAL RESEARCH GLOBAL INVESTORS removed 4,702,362 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,820,438,309
• MORGAN STANLEY removed 4,607,764 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,723,464,954

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BLK Analyst Ratings

Wall Street analysts have issued reports on $BLK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Deutsche Bank issued a "Buy" rating on 01/16/2025
• Goldman Sachs issued a "Buy" rating on 01/15/2025
• Wells Fargo issued a "Overweight" rating on 01/07/2025
• Evercore ISI issued a "Outperform" rating on 12/03/2024
• Citigroup issued a "Buy" rating on 10/14/2024

To track analyst ratings and price targets for BLK, check out Quiver Quantitative's $BLK forecast page.

BLK Price Targets

Multiple analysts have issued price targets for $BLK recently. We have seen 7 analysts offer price targets for $BLK in the last 6 months, with a median target of $1160.0.

Here are some recent targets:

• Michael Brown from Wells Fargo set a target price of $1175.0 on 01/16/2025
• Benjamin Budish from Barclays set a target price of $1160.0 on 01/13/2025
• Glenn Schorr from Evercore ISI set a target price of $1180.0 on 12/03/2024
• Chris Allen from Citigroup set a target price of $1150.0 on 10/14/2024
• Michael Cyprys from Morgan Stanley set a target price of $1245.0 on 10/14/2024
• Brian Bedell from Deutsche Bank set a target price of $1105.0 on 10/14/2024
• Alexander Blostein from Goldman Sachs set a target price of $1118.0 on 10/11/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of UNION PACIFIC CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

UNP Congressional Stock Trading

Members of Congress have traded $UNP stock 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UNP stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 02/25.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 3 purchases worth up to $45,000 on 02/03, 01/29, 12/13 and 0 sales.
• REPRESENTATIVE MIKE KELLY sold up to $50,000 on 11/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UNP Insider Trading Activity

UNP insiders have traded $UNP stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $UNP stock by insiders over the last 6 months:

• ELIZABETH F WHITED (PRESIDENT) sold 7,500 shares for an estimated $1,875,000
• CRAIG V RICHARDSON (EVP CHIEF LEGAL OFFICER & CORP) has made 0 purchases and 2 sales selling 6,495 shares for an estimated $1,636,740.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UNP Hedge Fund Activity

We have seen 1,068 institutional investors add shares of UNP stock to their portfolio, and 1,141 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,059,010 shares (-73.8%) from their portfolio in Q4 2024, for an estimated $697,576,640
• JPMORGAN CHASE & CO added 2,163,404 shares (+25.3%) to their portfolio in Q4 2024, for an estimated $493,342,648
• BANK OF AMERICA CORP /DE/ removed 1,632,268 shares (-13.8%) from their portfolio in Q4 2024, for an estimated $372,222,394
• GEODE CAPITAL MANAGEMENT, LLC added 1,616,895 shares (+12.6%) to their portfolio in Q4 2024, for an estimated $368,716,735
• CAPITAL INTERNATIONAL INVESTORS removed 1,616,851 shares (-15.7%) from their portfolio in Q4 2024, for an estimated $368,706,702
• BLACKROCK, INC. added 1,605,645 shares (+3.7%) to their portfolio in Q4 2024, for an estimated $366,151,285
• CAPITAL RESEARCH GLOBAL INVESTORS added 1,298,178 shares (+14.3%) to their portfolio in Q4 2024, for an estimated $296,036,511

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UNP Analyst Ratings

Wall Street analysts have issued reports on $UNP in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Loop Capital Markets issued a "Sell" rating on 02/03/2025
• Goldman Sachs issued a "Buy" rating on 01/23/2025
• Raymond James issued a "Strong Buy" rating on 01/10/2025
• Wells Fargo issued a "Overweight" rating on 01/07/2025

To track analyst ratings and price targets for UNP, check out Quiver Quantitative's $UNP forecast page.

UNP Price Targets

Multiple analysts have issued price targets for $UNP recently. We have seen 4 analysts offer price targets for $UNP in the last 6 months, with a median target of $265.0.

Here are some recent targets:

• An analyst from Deutsche Bank set a target price of $295.0 on 03/07/2025
• Rick Paterson from Loop Capital Markets set a target price of $200.0 on 02/03/2025
• Patrick Tyler Brown from Raymond James set a target price of $265.0 on 01/10/2025
• Christian Wetherbee from Wells Fargo set a target price of $265.0 on 01/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$PED ($PED) is expected to release its quarterly earnings data on Monday, April 7th before market open, per Finnhub. Analysts are expecting revenue of $9,385,253 and earnings of $0.01 per share.

You can see Quiver Quantitative's $PED stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

$PED Insider Trading Activity

$PED insiders have traded $PED stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $PED stock by insiders over the last 6 months:

• JOHN DOUGLAS SCHICK (President and CEO) has made 0 purchases and 2 sales selling 178,334 shares for an estimated $141,182.
• MOORE CLARK (Executive VP) has made 0 purchases and 2 sales selling 175,000 shares for an estimated $137,967.
• PAUL ANTHONY PINKSTON (CAO and PFO and AO) has made 0 purchases and 3 sales selling 123,000 shares for an estimated $94,981.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PED Hedge Fund Activity

We have seen 8 institutional investors add shares of $PED stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC added 130,349 shares (+232.5%) to their portfolio in Q4 2024, for an estimated $101,411
• UBS GROUP AG added 70,398 shares (+51.8%) to their portfolio in Q4 2024, for an estimated $54,769
• RENAISSANCE TECHNOLOGIES LLC added 48,132 shares (+19.7%) to their portfolio in Q4 2024, for an estimated $37,446
• VIRTU FINANCIAL LLC added 21,499 shares (+129.9%) to their portfolio in Q4 2024, for an estimated $16,726
• SPIRE WEALTH MANAGEMENT removed 16,371 shares (-81.9%) from their portfolio in Q4 2024, for an estimated $12,736
• GROUND SWELL CAPITAL, LLC added 11,377 shares (+inf%) to their portfolio in Q4 2024, for an estimated $8,851
• BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 4,700 shares (-1.6%) from their portfolio in Q4 2024, for an estimated $3,656

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

GENELUX ($GNLX) is expected to release its quarterly earnings data on Monday, April 7th before market open, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.19 per share.

You can see Quiver Quantitative's $GNLX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

GENELUX Insider Trading Activity

GENELUX insiders have traded $GNLX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $GNLX stock by insiders over the last 6 months:

• THOMAS ZINDRICK (President and CEO) sold 14,315 shares for an estimated $33,497
• JOSEPH CAPPELLO (VP, Pharmaceutical Development) sold 6,300 shares for an estimated $14,742
• JAMES L TYREE sold 3,460 shares for an estimated $8,511
• RALPH SMALLING (Head of Regulatory) sold 2,510 shares for an estimated $5,873
• LOURIE S. ZAK (Chief Financial Officer) sold 2,103 shares for an estimated $4,921

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GENELUX Hedge Fund Activity

We have seen 18 institutional investors add shares of GENELUX stock to their portfolio, and 26 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MILLENNIUM MANAGEMENT LLC removed 214,419 shares (-58.8%) from their portfolio in Q4 2024, for an estimated $506,028
• VANGUARD GROUP INC added 201,967 shares (+20.5%) to their portfolio in Q4 2024, for an estimated $476,642
• RENAISSANCE TECHNOLOGIES LLC removed 107,986 shares (-88.1%) from their portfolio in Q4 2024, for an estimated $254,846
• AFFINITY ASSET ADVISORS, LLC removed 100,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $236,000
• WOODWARD DIVERSIFIED CAPITAL, LLC removed 75,058 shares (-5.6%) from their portfolio in Q4 2024, for an estimated $177,136
• D. E. SHAW & CO., INC. removed 55,012 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $129,828
• MARSHALL WACE, LLP added 52,958 shares (+51.4%) to their portfolio in Q4 2024, for an estimated $124,980

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GENELUX Analyst Ratings

Wall Street analysts have issued reports on $GNLX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 10/28/2024

To track analyst ratings and price targets for GENELUX, check out Quiver Quantitative's $GNLX forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

We just received data on a new analyst forecast for $PLTR. Loop Capital Markets gave a rating of 'Buy' for $PLTR.

$PLTR Analyst Ratings

Wall Street analysts have issued reports on $PLTR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Loop Capital Markets issued a "Buy" rating on 04/04/2025
• Bank of America Securities issued a "Buy" rating on 02/12/2025
• RBC Capital issued a "Underperform" rating on 02/04/2025
• Jefferies issued a "Underperform" rating on 02/04/2025
• Wedbush issued a "Outperform" rating on 01/23/2025

To track analyst ratings and price targets for $PLTR, check out Quiver Quantitative's $PLTR forecast page.

$PLTR Price Targets

Multiple analysts have issued price targets for $PLTR recently. We have seen 6 analysts offer price targets for $PLTR in the last 6 months, with a median target of $82.0.

Here are some recent targets:

• An analyst from William Blair set a target price of $84.0 on 03/05/2025
• Gil Luria from D.A. Davidson set a target price of $105.0 on 02/04/2025
• Gregg Moskowitz from Mizuho Securities set a target price of $80.0 on 02/04/2025
• Sanjit Singh from Morgan Stanley set a target price of $95.0 on 02/04/2025
• Brent Thill from Jefferies set a target price of $60.0 on 02/04/2025
• Dan Ives from Wedbush set a target price of $75.0 on 11/25/2024

$PLTR Congressional Stock Trading

Members of Congress have traded $PLTR stock 8 times in the past 6 months. Of those trades, 6 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 02/25 and 2 sales worth up to $30,000 on 02/26, 02/25.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/12, 01/15 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 02/12.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/24.
• REPRESENTATIVE JAMES COMER purchased up to $15,000 on 01/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$PLTR Insider Trading Activity

$PLTR insiders have traded $PLTR stock on the open market 261 times in the past 6 months. Of those trades, 0 have been purchases and 261 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by insiders over the last 6 months:

• ALEXANDER C. KARP (See Remarks) has made 0 purchases and 42 sales selling 28,407,565 shares for an estimated $1,579,775,513.
• STEPHEN ANDREW COHEN (See Remarks) has made 0 purchases and 58 sales selling 6,399,862 shares for an estimated $523,902,748.
• SHYAM SANKAR (See Remarks) has made 0 purchases and 46 sales selling 6,035,041 shares for an estimated $440,199,184.
• RYAN D. TAYLOR (See Remarks) has made 0 purchases and 18 sales selling 978,107 shares for an estimated $62,311,079.
• DAVID A. GLAZER (See Remarks) has made 0 purchases and 13 sales selling 478,184 shares for an estimated $34,250,882.
• ALEXANDER D. MOORE has made 0 purchases and 25 sales selling 120,000 shares for an estimated $8,716,146.
• HEATHER A. PLANISHEK (See Remarks) has made 0 purchases and 34 sales selling 112,405 shares for an estimated $8,053,786.
• LAUREN ELAINA FRIEDMAN STAT has made 0 purchases and 8 sales selling 58,296 shares for an estimated $4,066,093.
• ALEXANDRA W. SCHIFF has made 0 purchases and 17 sales selling 14,776 shares for an estimated $1,288,868.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PLTR Hedge Fund Activity

We have seen 1,114 institutional investors add shares of $PLTR stock to their portfolio, and 641 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC removed 22,597,915 shares (-9.3%) from their portfolio in Q4 2024, for an estimated $1,709,080,311
• RENAISSANCE TECHNOLOGIES LLC removed 15,629,431 shares (-40.7%) from their portfolio in Q4 2024, for an estimated $1,182,053,866
• BLACKROCK, INC. added 14,450,765 shares (+9.2%) to their portfolio in Q4 2024, for an estimated $1,092,911,356
• D. E. SHAW & CO., INC. removed 8,830,658 shares (-81.5%) from their portfolio in Q4 2024, for an estimated $667,862,664
• NORGES BANK added 6,728,869 shares (+59.8%) to their portfolio in Q4 2024, for an estimated $508,904,362
• MORGAN STANLEY added 6,008,349 shares (+26.3%) to their portfolio in Q4 2024, for an estimated $454,411,434
• GOLDMAN SACHS GROUP INC added 5,863,049 shares (+89.4%) to their portfolio in Q4 2024, for an estimated $443,422,395

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$JILL stock has now risen 7% today, according to our price data from Polygon. There has been approximately $1,659,763 of trading volume.

$JILL Insider Trading Activity

$JILL insiders have traded $JILL stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $JILL stock by insiders over the last 6 months:

• CLAIRE SPOFFORD (President & CEO) has made 0 purchases and 17 sales selling 62,796 shares for an estimated $1,658,186.
• MARK W. WEBB (EVP, CFO & COO) has made 0 purchases and 2 sales selling 8,088 shares for an estimated $229,213.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$JILL Hedge Fund Activity

We have seen 44 institutional investors add shares of $JILL stock to their portfolio, and 50 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ROYCE & ASSOCIATES LP added 153,568 shares (+36.4%) to their portfolio in Q4 2024, for an estimated $4,241,548
• MORGAN STANLEY removed 125,853 shares (-76.8%) from their portfolio in Q4 2024, for an estimated $3,476,059
• CITADEL ADVISORS LLC removed 98,189 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,711,980
• FUND 1 INVESTMENTS, LLC added 96,982 shares (+48.1%) to their portfolio in Q4 2024, for an estimated $2,678,642
• CENTERBOOK PARTNERS LP removed 96,127 shares (-29.1%) from their portfolio in Q4 2024, for an estimated $2,655,027
• EXODUSPOINT CAPITAL MANAGEMENT, LP removed 94,222 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,602,411
• DIVISADERO STREET CAPITAL MANAGEMENT, LP added 91,545 shares (+6.1%) to their portfolio in Q4 2024, for an estimated $2,528,472

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $JILL on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$DERM stock has now risen 8% today, according to our price data from Polygon. There has been approximately $1,176,427 of trading volume.

$DERM Insider Trading Activity

$DERM insiders have traded $DERM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $DERM stock by insiders over the last 6 months:

• CLAUDE MARAOUI (President & CEO) has made 0 purchases and 6 sales selling 160,283 shares for an estimated $811,060.
• JOSEPH BENESCH (CFO) sold 1,365 shares for an estimated $7,084

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DERM Hedge Fund Activity

We have seen 18 institutional investors add shares of $DERM stock to their portfolio, and 16 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• TANG CAPITAL MANAGEMENT LLC added 1,725,569 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,746,974
• ROSALIND ADVISORS, INC. removed 105,917 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $414,135
• CITADEL ADVISORS LLC added 44,568 shares (+inf%) to their portfolio in Q4 2024, for an estimated $174,260
• NEUBERGER BERMAN GROUP LLC removed 35,899 shares (-55.7%) from their portfolio in Q4 2024, for an estimated $140,365
• RENAISSANCE TECHNOLOGIES LLC removed 32,200 shares (-12.0%) from their portfolio in Q4 2024, for an estimated $125,902
• ACADIAN ASSET MANAGEMENT LLC removed 24,353 shares (-58.4%) from their portfolio in Q4 2024, for an estimated $95,220
• WALLEYE CAPITAL LLC removed 23,098 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $90,313

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DERM Analyst Ratings

Wall Street analysts have issued reports on $DERM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Alliance Global Partners issued a "Buy" rating on 03/27/2025

To track analyst ratings and price targets for $DERM, check out Quiver Quantitative's $DERM forecast page.

You can track data on $DERM on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$GME stock has now risen 4% today, according to our price data from Polygon. There has been approximately $178,391,792 of trading volume.

$GME Insider Trading Activity

$GME insiders have traded $GME stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $GME stock by insiders over the last 6 months:

• MARK HAYMOND ROBINSON (General Counsel and Secretary) has made 0 purchases and 2 sales selling 12,577 shares for an estimated $278,060.
• DANIEL WILLIAM MOORE (PFO and PAO) has made 0 purchases and 3 sales selling 5,895 shares for an estimated $134,012.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GME Hedge Fund Activity

We have seen 198 institutional investors add shares of $GME stock to their portfolio, and 82 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 3,007,031 shares (+1634.7%) to their portfolio in Q4 2024, for an estimated $94,240,351
• BLACKROCK, INC. added 2,579,416 shares (+8.0%) to their portfolio in Q4 2024, for an estimated $80,838,897
• JANE STREET GROUP, LLC added 2,085,409 shares (+1776.3%) to their portfolio in Q4 2024, for an estimated $65,356,718
• VANGUARD GROUP INC added 2,036,032 shares (+5.5%) to their portfolio in Q4 2024, for an estimated $63,809,242
• SLATE PATH CAPITAL LP added 1,926,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $60,360,840
• D. E. SHAW & CO., INC. added 1,417,156 shares (+606.7%) to their portfolio in Q4 2024, for an estimated $44,413,669
• CITADEL ADVISORS LLC added 1,258,226 shares (+52.4%) to their portfolio in Q4 2024, for an estimated $39,432,802

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$GME Analyst Ratings

Wall Street analysts have issued reports on $GME in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Underperform" rating on 03/26/2025

To track analyst ratings and price targets for $GME, check out Quiver Quantitative's $GME forecast page.

You can track data on $GME on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$NKE stock has now risen 3% today, according to our price data from Polygon. There has been approximately $1,851,636,038 of trading volume.

$NKE Insider Trading Activity

$NKE insiders have traded $NKE stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $NKE stock by insiders over the last 6 months:

• MARK G PARKER (EXECUTIVE CHAIRMAN) has made 0 purchases and 3 sales selling 214,922 shares for an estimated $15,824,943.
• HEIDI O'NEILL (PRES: CONSUMER, PRODCT & BRAND) sold 14,147 shares for an estimated $1,006,983
• ROBERT LEINWAND (EVP: Chief Legal Officer) sold 4,506 shares for an estimated $328,081
• JOHN W JR ROGERS purchased 2,500 shares for an estimated $191,624

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NKE Hedge Fund Activity

We have seen 791 institutional investors add shares of $NKE stock to their portfolio, and 1,234 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP added 8,898,591 shares (+32.4%) to their portfolio in Q4 2024, for an estimated $673,356,380
• PACER ADVISORS, INC. added 6,709,985 shares (+6029.6%) to their portfolio in Q4 2024, for an estimated $507,744,564
• GOLDMAN SACHS GROUP INC removed 4,174,178 shares (-37.6%) from their portfolio in Q4 2024, for an estimated $315,860,049
• CAPITAL INTERNATIONAL INVESTORS removed 4,065,694 shares (-23.6%) from their portfolio in Q4 2024, for an estimated $307,651,064
• BANK OF AMERICA CORP /DE/ removed 3,601,743 shares (-26.7%) from their portfolio in Q4 2024, for an estimated $272,543,892
• LAZARD ASSET MANAGEMENT LLC removed 3,505,519 shares (-86.7%) from their portfolio in Q4 2024, for an estimated $265,262,622
• BANK OF NEW YORK MELLON CORP added 3,121,929 shares (+18.1%) to their portfolio in Q4 2024, for an estimated $236,236,367

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$NKE Congressional Stock Trading

Members of Congress have traded $NKE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NKE stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 01/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$NKE Analyst Ratings

Wall Street analysts have issued reports on $NKE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 02/03/2025
• Piper Sandler issued a "Overweight" rating on 01/10/2025
• Bernstein issued a "Outperform" rating on 10/14/2024

To track analyst ratings and price targets for $NKE, check out Quiver Quantitative's $NKE forecast page.

$NKE Price Targets

Multiple analysts have issued price targets for $NKE recently. We have seen 4 analysts offer price targets for $NKE in the last 6 months, with a median target of $90.0.

Here are some recent targets:

• An analyst from Morgan Stanley set a target price of $70.0 on 03/21/2025
• Anna Andreeva from Piper Sandler set a target price of $90.0 on 01/10/2025
• Katherine Griffin from Griffin set a target price of $90.0 on 10/10/2024
• Joseph Civello from Truist Financial set a target price of $97.0 on 10/10/2024

You can track data on $NKE on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

We just received data on a new analyst forecast for $GBX. Stephens gave a rating of 'Overweight' for $GBX.

$GBX Analyst Ratings

Wall Street analysts have issued reports on $GBX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Stephens issued a "Overweight" rating on 04/04/2025
• Susquehanna issued a "Positive" rating on 01/09/2025

To track analyst ratings and price targets for $GBX, check out Quiver Quantitative's $GBX forecast page.

$GBX Insider Trading Activity

$GBX insiders have traded $GBX stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $GBX stock by insiders over the last 6 months:

• BRIAN J COMSTOCK (EVP & President, The Americas) has made 0 purchases and 3 sales selling 55,000 shares for an estimated $3,490,893.
• WILLIAM J. KRUEGER (SVP, COO, The Americas) has made 0 purchases and 11 sales selling 12,389 shares for an estimated $763,860.
• RICARDO GALVAN (SVP, Operations, Maint Svcs.) has made 0 purchases and 3 sales selling 8,314 shares for an estimated $522,414.
• MARTIN RAYMOND BAKER (Senior Vice President) sold 8,285 shares for an estimated $517,771

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GBX Hedge Fund Activity

We have seen 122 institutional investors add shares of $GBX stock to their portfolio, and 111 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• LSV ASSET MANAGEMENT added 264,552 shares (+94.3%) to their portfolio in Q4 2024, for an estimated $16,135,026
• UBS GROUP AG added 221,447 shares (+776.7%) to their portfolio in Q4 2024, for an estimated $13,506,052
• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 204,020 shares (-27.4%) from their portfolio in Q4 2024, for an estimated $12,443,179
• ENCOMPASS CAPITAL ADVISORS LLC added 193,340 shares (+26.2%) to their portfolio in Q4 2024, for an estimated $11,791,806
• GOLDMAN SACHS GROUP INC added 172,367 shares (+68.1%) to their portfolio in Q4 2024, for an estimated $10,512,663
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 158,568 shares (+inf%) to their portfolio in Q4 2024, for an estimated $9,671,062
• BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 136,424 shares (-8.5%) from their portfolio in Q4 2024, for an estimated $8,320,499

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$49,000 of HEALTHPEAK PROPERTIES INC. FKA PHYSICIANS REALTY TRUST lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"monitor legislation affecting real estate investment trusts oppose legislation prohibiting REITs ownership of healthcare property; monitor BioSecure legislation oppose adoption of Corporate SALT provisions monitor legislation affecting site neutral cuts in Medicare"

You can find more data on corporate lobbying on Quiver Quantitative.

DOC Hedge Fund Activity

We have seen 328 institutional investors add shares of DOC stock to their portfolio, and 346 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRINCIPAL FINANCIAL GROUP INC added 17,314,572 shares (+2113.5%) to their portfolio in Q4 2024, for an estimated $350,966,374
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,335,740 shares (-82.5%) from their portfolio in Q4 2024, for an estimated $128,425,449
• RESOLUTION CAPITAL LTD added 6,057,961 shares (+inf%) to their portfolio in Q4 2024, for an estimated $122,794,869
• LONG POND CAPITAL, LP added 4,286,388 shares (+inf%) to their portfolio in Q4 2024, for an estimated $86,885,084
• MILLENNIUM MANAGEMENT LLC removed 3,693,635 shares (-83.1%) from their portfolio in Q4 2024, for an estimated $74,869,981
• CITADEL ADVISORS LLC removed 3,635,307 shares (-93.6%) from their portfolio in Q4 2024, for an estimated $73,687,672
• LASALLE INVESTMENT MANAGEMENT SECURITIES LLC removed 3,062,026 shares (-86.9%) from their portfolio in Q4 2024, for an estimated $62,067,267

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DOC Analyst Ratings

Wall Street analysts have issued reports on $DOC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Deutsche Bank issued a "Buy" rating on 10/21/2024

To track analyst ratings and price targets for DOC, check out Quiver Quantitative's $DOC forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,865 of LOCKHEED MARTIN AERONAUTIC SECTOR lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Armed Services Committee: tactical aircraft issues, space based radar;GP;C-130J;foreign military sales; support helicopter funding; support space hardening; JASSM funding; support JADC2; monitor for defense spectrum issues Defense Appropriation: tactical aircraft issues, space based radar;GP;C-130J;foreign military sales; support helicopter funding; support space hardening; JASSM funding;support funding for helicopters and equipment for wildfire firefighting ratification of law of the sea support defense financing provisions monitor for provisions related to corporate SALT taxation"

You can find more data on corporate lobbying on Quiver Quantitative.

LMT Congressional Stock Trading

Members of Congress have traded $LMT stock 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $LMT stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.
• REPRESENTATIVE SCOTT FRANKLIN has traded it 3 times. They made 3 purchases worth up to $80,000 on 02/18 and 0 sales.
• REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/13.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

LMT Insider Trading Activity

LMT insiders have traded $LMT stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $LMT stock by insiders over the last 6 months:

• STEPHANIE C. HILL (Pres. Rotary & Mission Systems) sold 4,791 shares for an estimated $2,120,041
• ROBERT M JR LIGHTFOOT (President Space) sold 3,213 shares for an estimated $1,421,506
• HARRY EDWARD III PAUL (Vice President & Controller) sold 707 shares for an estimated $312,923

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LMT Hedge Fund Activity

We have seen 1,151 institutional investors add shares of LMT stock to their portfolio, and 1,143 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PROFICIO CAPITAL PARTNERS LLC added 1,233,275 shares (+53784.3%) to their portfolio in Q4 2024, for an estimated $599,297,653
• CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 1,132,461 shares (+17.9%) to their portfolio in Q4 2024, for an estimated $550,308,098
• BLACKROCK, INC. removed 1,103,118 shares (-6.2%) from their portfolio in Q4 2024, for an estimated $536,049,160
• CASTLEKEEP INVESTMENT ADVISORS LLC added 1,081,492 shares (+50208.5%) to their portfolio in Q4 2024, for an estimated $525,540,222
• WELLS FARGO & COMPANY/MN removed 550,659 shares (-22.0%) from their portfolio in Q4 2024, for an estimated $267,587,234
• VAN ECK ASSOCIATES CORP added 507,312 shares (+1239.6%) to their portfolio in Q4 2024, for an estimated $246,523,193
• BARCLAYS PLC removed 485,234 shares (-45.7%) from their portfolio in Q4 2024, for an estimated $235,794,609

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LMT Analyst Ratings

Wall Street analysts have issued reports on $LMT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Cowen & Co. issued a "Buy" rating on 10/23/2024
• Susquehanna issued a "Positive" rating on 10/23/2024
• Goldman Sachs issued a "Sell" rating on 10/23/2024
• Citigroup issued a "Buy" rating on 10/10/2024

To track analyst ratings and price targets for LMT, check out Quiver Quantitative's $LMT forecast page.

LMT Price Targets

Multiple analysts have issued price targets for $LMT recently. We have seen 8 analysts offer price targets for $LMT in the last 6 months, with a median target of $564.0.

Here are some recent targets:

• An analyst from Wells Fargo set a target price of $476.0 on 03/07/2025
• Peter Arment from Robert W. Baird set a target price of $540.0 on 01/14/2025
• Douglas Harned from Bernstein set a target price of $548.0 on 01/10/2025
• Sheila Kahyaoglu from Jefferies set a target price of $580.0 on 10/30/2024
• Charles Minervino from Susquehanna set a target price of $695.0 on 10/23/2024
• Ken Herbert from RBC Capital set a target price of $665.0 on 10/23/2024
• Noah Poponak from Goldman Sachs set a target price of $434.0 on 10/23/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$52,500 of ZIONS BANCORP lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"monitor for legislation affecting small business loans monitor for PPP legislation support Congressional efforts to require large credit unions to become taxable monitor PPP legislation monitor legislation regarding ESG oppose the use of the USPS for banking work to mitigate proposed SEC rule on ESG monitor assessment date for FDIC insurance recapitalization monitor for legislation regarding long term debt regulations"

You can find more data on corporate lobbying on Quiver Quantitative.

TBBK Insider Trading Activity

TBBK insiders have traded $TBBK stock on the open market 16 times in the past 6 months. Of those trades, 6 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $TBBK stock by insiders over the last 6 months:

• JOHN LETO (EVP Head of Institutional Bank) sold 51,000 shares for an estimated $2,932,964
• JEFFREY A NAGER (EVP Head of Commercial Lending) has made 0 purchases and 2 sales selling 22,663 shares for an estimated $1,387,763.
• MARIA WAINWRIGHT (EVP Chief Marketing Officer) sold 11,357 shares for an estimated $568,726
• MATTHEW J WALLACE (EVP and CIO) sold 10,160 shares for an estimated $508,653
• RYAN HARRIS (EVP Head of Fintech Solutions) sold 7,500 shares for an estimated $460,634
• TODD J. BROCKMAN has made 2 purchases buying 8,217 shares for an estimated $454,420 and 0 sales.
• ERIKA R CAESAR (EVP and General Counsel) sold 5,000 shares for an estimated $301,630
• THOMAS G. PAREIGAT (EVP and General Counsel) sold 5,466 shares for an estimated $267,982
• MARK E TRYNISKI purchased 5,000 shares for an estimated $251,803
• JENNIFER F TERRY (EVP and Chief HR Officer) sold 3,798 shares for an estimated $229,003
• GREGOR J GARRY (EVP and COO) sold 1,500 shares for an estimated $91,564
• MATTHEW COHN has made 3 purchases buying 1,065 shares for an estimated $53,269 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TBBK Hedge Fund Activity

We have seen 98 institutional investors add shares of TBBK stock to their portfolio, and 146 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CASTLE CREEK CAPITAL PARTNERS VI, LP removed 1,160,000 shares (-69.7%) from their portfolio in Q4 2024, for an estimated $61,050,800
• AMERICAN CENTURY COMPANIES INC added 631,744 shares (+35.9%) to their portfolio in Q4 2024, for an estimated $33,248,686
• OWLS NEST PARTNERS IA, LLC added 474,185 shares (+103.5%) to their portfolio in Q4 2024, for an estimated $24,956,356
• INVESCO LTD. added 466,795 shares (+26.2%) to their portfolio in Q4 2024, for an estimated $24,567,420
• UBS GROUP AG added 454,341 shares (+445.3%) to their portfolio in Q4 2024, for an estimated $23,911,966
• NANTAHALA CAPITAL MANAGEMENT, LLC added 386,295 shares (+65.7%) to their portfolio in Q4 2024, for an estimated $20,330,705
• STATE STREET CORP added 366,596 shares (+12.0%) to their portfolio in Q4 2024, for an estimated $19,293,947

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TBBK Analyst Ratings

Wall Street analysts have issued reports on $TBBK in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Outperform" rating on 12/30/2024
• Piper Sandler issued a "Overweight" rating on 12/16/2024
• Stephens issued a "Overweight" rating on 12/09/2024

To track analyst ratings and price targets for TBBK, check out Quiver Quantitative's $TBBK forecast page.

TBBK Price Targets

Multiple analysts have issued price targets for $TBBK recently. We have seen 2 analysts offer price targets for $TBBK in the last 6 months, with a median target of $79.0.

Here are some recent targets:

• David Rochester from Compass Point set a target price of $125.0 on 12/10/2024
• Terry McEvoy from Stephens set a target price of $33.0 on 12/09/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$45,000 of ALIGNMENT HEALTHCARE INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Medicare Advantage"

You can find more data on corporate lobbying on Quiver Quantitative.

ALHC Insider Trading Activity

ALHC insiders have traded $ALHC stock on the open market 83 times in the past 6 months. Of those trades, 0 have been purchases and 83 have been sales.

Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:

• JOHN E KAO (Chief Executive Officer) has made 0 purchases and 15 sales selling 1,243,901 shares for an estimated $18,188,757.
• ROBERT THOMAS FREEMAN (Chief Financial Officer) has made 0 purchases and 13 sales selling 655,978 shares for an estimated $9,777,462.
• DAWN CHRISTINE MARONEY (President) has made 0 purchases and 13 sales selling 540,961 shares for an estimated $7,983,737.
• HAKAN KARDES (Chief Experience Officer) has made 0 purchases and 12 sales selling 215,342 shares for an estimated $3,232,356.
• HYONG KIM (Chief Medical Officer) has made 0 purchases and 9 sales selling 162,628 shares for an estimated $2,261,074.
• CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 6 sales selling 78,612 shares for an estimated $1,314,336.
• ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 7 sales selling 74,737 shares for an estimated $1,178,518.
• ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 27,398 shares for an estimated $421,679.
• SEBASTIAN BURZACCHI (COO - Mgmt Services Org) has made 0 purchases and 3 sales selling 15,244 shares for an estimated $206,061.
• JOSEPH S KONOWIECKI sold 6,920 shares for an estimated $95,011

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ALHC Hedge Fund Activity

We have seen 104 institutional investors add shares of ALHC stock to their portfolio, and 48 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WARBURG PINCUS LLC removed 13,622,779 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $153,256,263
• DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 3,550,683 shares (-32.7%) from their portfolio in Q4 2024, for an estimated $39,945,183
• WELLINGTON MANAGEMENT GROUP LLP added 3,257,630 shares (+77.9%) to their portfolio in Q4 2024, for an estimated $36,648,337
• CITADEL ADVISORS LLC added 3,088,765 shares (+inf%) to their portfolio in Q4 2024, for an estimated $34,748,606
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,059,596 shares (+54.7%) to their portfolio in Q4 2024, for an estimated $34,420,455
• MILLENNIUM MANAGEMENT LLC added 2,896,311 shares (+588.3%) to their portfolio in Q4 2024, for an estimated $32,583,498
• POINT72 ASSET MANAGEMENT, L.P. added 1,785,480 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,086,650

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ALHC Analyst Ratings

Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Piper Sandler issued a "Overweight" rating on 03/04/2025
• Cowen & Co. issued a "Buy" rating on 10/31/2024
• Barclays issued a "Underweight" rating on 10/30/2024

To track analyst ratings and price targets for ALHC, check out Quiver Quantitative's $ALHC forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Representative David Taylor just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative David Taylor and other politicians.

The trades in the new disclosure included a:

• Sale of $JPM stock (JP MORGAN CHASE & CO. COMMON STOCK)
• Purchase of $PH stock (PARKER-HANNIFIN CORPORATION COMMON STOCK)
• Purchase of $PG stock (PROCTER & GAMBLE COMPANY)
• Sale of $SJM stock (THE J.M. SMUCKER COMPANY COMMON STOCK)
• Sale of $V stock (VISA INC.)
• Purchase of $IBP stock (INSTALLED BUILDING PRODUCTS, INC. COMMON STOCK)
• Purchase of $KR stock (KROGER COMPANY)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative David Taylor

$AMS ($AMS) posted quarterly earnings results on Friday, April 4th. The company reported earnings of -$0.20 per share, missing estimates of $0.01 by $0.21. The company also reported revenue of $9,070,000, beating estimates of $7,777,000 by $1,293,000.

You can see Quiver Quantitative's $AMS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

$AMS Hedge Fund Activity

We have seen 6 institutional investors add shares of $AMS stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ACADIAN ASSET MANAGEMENT LLC removed 23,682 shares (-57.4%) from their portfolio in Q4 2024, for an estimated $75,545
• STATE STREET CORP added 12,101 shares (+inf%) to their portfolio in Q4 2024, for an estimated $38,602
• TWO SIGMA INVESTMENTS, LP removed 10,515 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $33,542
• RENAISSANCE TECHNOLOGIES LLC added 3,776 shares (+5.6%) to their portfolio in Q4 2024, for an estimated $12,045
• TOWER RESEARCH CAPITAL LLC (TRC) added 938 shares (+259.1%) to their portfolio in Q4 2024, for an estimated $2,992
• UBS GROUP AG removed 896 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,858
• DIMENSIONAL FUND ADVISORS LP added 603 shares (+0.3%) to their portfolio in Q4 2024, for an estimated $1,923

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Senator Mark R. Warner lost $3.6M in the stock market last month, per Quiver Quantitative's live net worth estimates.

Senator Mark R. Warner Net Worth

Quiver Quantitative estimates that Senator Mark R. Warner is worth $240.5M, as of April 4th, 2025. This is the 4th highest net worth in Congress, per our live estimates.

Warner has approximately $94.7M invested in publicly traded assets which Quiver is able to track live.

You can track Senator Mark R. Warner's net worth on Quiver Quantitative's politician page for Warner.

Senator Mark R. Warner Stock Trading

We have data on up to $97.9M of trades from Senator Mark R. Warner, which we parsed from STOCK Act filings. Some of the largest trades include:

• A February 19th, 2019 sale of up to $5M of $CHTR. The stock has risen 5.73% since then.
• A October 18th, 2017 sale of up to $5M of $XON. The stock has fallen 74.51% since then.
• A February 19th, 2019 sale of up to $1M of $ZAYO. The stock has risen 37.49% since then.
• A November 6th, 2017 sale of up to $1M of $HALO. The stock has risen 264.02% since then.
• A August 8th, 2023 sale of up to $500K of $ROAD. The stock has risen 110.14% since then.

Senator Mark R. Warner Bill Proposals

Here are some bills which have recently been proposed by Senator Mark R. Warner:

• S.1176: A bill to amend the Internal Revenue Code of 1986 to establish a new tax credit and grant program to stimulate investment and healthy nutrition options in food deserts, and for other purposes.
• S.1121: A bill to amend the Internal Revenue Code of 1986 to increase the adjusted gross income limitation for above-the-line deduction of expenses of performing artist employees, and for other purposes.
• S.1113: A bill to require the Secretary of the Treasury to conduct a study and prepare a report on the exposure of the United States to the financial sector of the People's Republic of China, and for other purposes.
• S.1058: Preserving Patient Access to Home Infusion Act
• S.980: Alleviating Spaceport Traffic by Rewarding Operators Act of 2025
• S.815: A bill to designate the outdoor amphitheater at the Blue Ridge Music Center in Galax, Virginia, as the "Rick Boucher Amphitheater".

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

Representative Nancy Pelosi lost $10.5M in the stock market last month, per Quiver Quantitative's live net worth estimates.

Representative Nancy Pelosi Net Worth

Quiver Quantitative estimates that Representative Nancy Pelosi is worth $246.8M, as of April 4th, 2025. This is the 3rd highest net worth in Congress, per our live estimates.

Pelosi has approximately $114.1M invested in publicly traded assets which Quiver is able to track live.

You can track Representative Nancy Pelosi's net worth on Quiver Quantitative's politician page for Pelosi.

Representative Nancy Pelosi Stock Trading

We have data on up to $267.4M of trades from Representative Nancy Pelosi, which we parsed from STOCK Act filings. Some of the largest trades include:

• A December 31st, 2024 sale of up to $25M of $AAPL. The stock has fallen 18.86% since then.
• A June 18th, 2020 purchase of up to $5M of $CRM. The stock has risen 36.01% since then.
• A June 21st, 2022 sale of up to $5M of $V. The stock has risen 74.59% since then.
• A June 26th, 2024 purchase of up to $5M of $NVDA. The stock has fallen 19.46% since then.
• A September 16th, 2022 purchase of up to $5M of $GOOG. The stock has risen 47.28% since then.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

$50,000 of DAVITA lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Dialysis services"

You can find more data on corporate lobbying on Quiver Quantitative.

DVA Insider Trading Activity

DVA insiders have traded $DVA stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

• HATHAWAY INC BERKSHIRE has made 0 purchases and 19 sales selling 953,091 shares for an estimated $147,740,046.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DVA Hedge Fund Activity

We have seen 218 institutional investors add shares of DVA stock to their portfolio, and 315 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 607,396 shares (+409.9%) to their portfolio in Q4 2024, for an estimated $90,836,071
• BLACKROCK, INC. removed 465,288 shares (-9.9%) from their portfolio in Q4 2024, for an estimated $69,583,820
• BANK OF AMERICA CORP /DE/ removed 431,630 shares (-69.0%) from their portfolio in Q4 2024, for an estimated $64,550,266
• EPOCH INVESTMENT PARTNERS, INC. added 368,436 shares (+inf%) to their portfolio in Q4 2024, for an estimated $55,099,603
• JPMORGAN CHASE & CO removed 332,508 shares (-59.2%) from their portfolio in Q4 2024, for an estimated $49,726,571
• CITADEL ADVISORS LLC removed 332,336 shares (-76.6%) from their portfolio in Q4 2024, for an estimated $49,700,848
• HOLOCENE ADVISORS, LP added 302,154 shares (+inf%) to their portfolio in Q4 2024, for an estimated $45,187,130

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

LIFECORE BIOMEDICAL ($LFCR) posted quarterly earnings results on Thursday, April 3rd. The company reported earnings of -$0.19 per share, missing estimates of -$0.15 by $0.04. The company also reported revenue of $35,150,000, beating estimates of $33,893,580 by $1,256,420.

You can see Quiver Quantitative's $LFCR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

LIFECORE BIOMEDICAL Insider Trading Activity

LIFECORE BIOMEDICAL insiders have traded $LFCR stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $LFCR stock by insiders over the last 6 months:

• CHRISTOPHER S KIPER has made 2 purchases buying 1,463,414 shares for an estimated $5,999,997 and 0 sales.
• PARTNERS SMALL CAP VALUE LP I WYNNEFIELD has made 2 purchases buying 292,683 shares for an estimated $1,200,000 and 0 sales.
• PAUL JOSEPHS (Chief Executive Officer) purchased 17,000 shares for an estimated $97,580

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LIFECORE BIOMEDICAL Hedge Fund Activity

We have seen 38 institutional investors add shares of LIFECORE BIOMEDICAL stock to their portfolio, and 38 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• LEGION PARTNERS ASSET MANAGEMENT, LLC added 1,463,414 shares (+49.3%) to their portfolio in Q4 2024, for an estimated $10,873,166
• GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. added 1,387,362 shares (+62.2%) to their portfolio in Q4 2024, for an estimated $10,308,099
• 325 CAPITAL LLC added 792,681 shares (+57.9%) to their portfolio in Q4 2024, for an estimated $5,889,619
• INVESCO LTD. added 555,607 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,128,160
• DEUTSCHE BANK AG\ removed 290,286 shares (-91.9%) from their portfolio in Q4 2024, for an estimated $2,156,824
• DCF ADVISERS, LLC added 251,511 shares (+87.2%) to their portfolio in Q4 2024, for an estimated $1,868,726
• WYNNEFIELD CAPITAL INC removed 215,763 shares (-4.4%) from their portfolio in Q4 2024, for an estimated $1,603,119

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LIFECORE BIOMEDICAL Analyst Ratings

Wall Street analysts have issued reports on $LFCR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Craig-Hallum issued a "Buy" rating on 11/22/2024

To track analyst ratings and price targets for LIFECORE BIOMEDICAL, check out Quiver Quantitative's $LFCR forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

GUESS ($GES) posted quarterly earnings results on Thursday, April 3rd. The company reported earnings of $1.48 per share, beating estimates of $1.39 by $0.09. The company also reported revenue of $932,250,000, beating estimates of $916,829,186 by $15,420,814.

You can see Quiver Quantitative's $GES stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

GUESS Hedge Fund Activity

We have seen 85 institutional investors add shares of GUESS stock to their portfolio, and 81 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HENNESSY ADVISORS INC removed 1,518,500 shares (-82.5%) from their portfolio in Q4 2024, for an estimated $21,350,110
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,363,997 shares (-95.0%) from their portfolio in Q4 2024, for an estimated $19,177,797
• PACER ADVISORS, INC. removed 968,361 shares (-23.9%) from their portfolio in Q4 2024, for an estimated $13,615,155
• MILLENNIUM MANAGEMENT LLC added 697,766 shares (+151.2%) to their portfolio in Q4 2024, for an estimated $9,810,589
• BANK OF NEW YORK MELLON CORP removed 423,013 shares (-69.3%) from their portfolio in Q4 2024, for an estimated $5,947,562
• VERITION FUND MANAGEMENT LLC added 291,222 shares (+1643.9%) to their portfolio in Q4 2024, for an estimated $4,094,581
• UBS GROUP AG added 282,160 shares (+3376.3%) to their portfolio in Q4 2024, for an estimated $3,967,169

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

SIMULATIONS PLUS ($SLP) posted quarterly earnings results on Thursday, April 3rd. The company reported earnings of $0.31 per share, beating estimates of $0.12 by $0.19. The company also reported revenue of $22,430,000, beating estimates of $22,144,250 by $285,750.

You can see Quiver Quantitative's $SLP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

SIMULATIONS PLUS Insider Trading Activity

SIMULATIONS PLUS insiders have traded $SLP stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $SLP stock by insiders over the last 6 months:

• WALTER S WOLTOSZ has made 0 purchases and 9 sales selling 120,000 shares for an estimated $3,479,691.
• DANIEL L WEINER sold 750 shares for an estimated $21,375
• LISA LAVANGE sold 650 shares for an estimated $20,722

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SIMULATIONS PLUS Hedge Fund Activity

We have seen 78 institutional investors add shares of SIMULATIONS PLUS stock to their portfolio, and 83 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• OPHIR ASSET MANAGEMENT PTY LTD removed 598,183 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $16,683,323
• JANUS HENDERSON GROUP PLC added 535,986 shares (+7753.3%) to their portfolio in Q4 2024, for an estimated $14,948,649
• VOYA INVESTMENT MANAGEMENT LLC removed 376,741 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $10,507,306
• CONESTOGA CAPITAL ADVISORS, LLC added 290,414 shares (+15.0%) to their portfolio in Q4 2024, for an estimated $8,099,646
• WASATCH ADVISORS LP removed 228,755 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $6,379,976
• RANGER INVESTMENT MANAGEMENT, L.P. removed 199,695 shares (-22.1%) from their portfolio in Q4 2024, for an estimated $5,569,493
• MORGAN STANLEY added 140,050 shares (+29.8%) to their portfolio in Q4 2024, for an estimated $3,905,994

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SIMULATIONS PLUS Government Contracts

We have seen $204,139 of award payments to $SLP over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• GASTROPLUS?, DDDPLUS AND MEMBRANEPLUS SOFTWARE LICENSES: $76,615
• SOFTWARE LICENSING FOR ANALYSIS RESEARCH EFFORTS.: $49,544
• SOFTWARE LICENSE: ADMET PREDICTOR & GASTROPLUS: $35,378
• ADMET PREDICTOR SOFTWARE LICENSE RENEWALS AND SUPPORT: $21,671
• SOFTWARE ANNUAL LICENSE 1 USER FOR ADMET AND GASTROPLUS: $20,928

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$12,900 of KEYSIGHT TECHNOLOGIES INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY2026 House and Senate Defense Appropriations and Authorization Bills: Acquisition Reform, Semiconductor Fabrication Facilities, CHIPS Act, F-35 and EW Programs. U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Natl Telecommunications & Information Administration (NTIA), Federal Communications Commission (FCC), Commerce - Dept of (DOC) STEM at early ages in order to foster more Women Engineers. Policy rules regarding spectrum sharing and use of frequencies above 95GHz and NextG standards. Trade issues with US equipment sales to China companies. ITAR and Export Control issues of foreign companies registered in the U.S. vs U.S. Companies. CHIPS Act - tax incentives. R&D Tax Credits. CHIPS Act and onshoring."

You can find more data on corporate lobbying on Quiver Quantitative.

KEYS Insider Trading Activity

KEYS insiders have traded $KEYS stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $KEYS stock by insiders over the last 6 months:

• RONALD S. NERSESIAN sold 41,911 shares for an estimated $7,142,221
• SOON CHAI GOOI (SVP) has made 0 purchases and 2 sales selling 26,915 shares for an estimated $4,596,976.
• SATISH DHANASEKARAN (President and CEO) sold 17,822 shares for an estimated $3,023,680
• NEIL DOUGHERTY (EVP and CFO) has made 0 purchases and 2 sales selling 7,264 shares for an estimated $1,125,920.
• MARK ADAM WALLACE (SVP) sold 6,000 shares for an estimated $970,769
• JEFFREY K LI (SVP and Secretary) sold 4,412 shares for an estimated $758,511
• JOHN PAGE (SVP) sold 3,884 shares for an estimated $658,959
• KAILASH NARAYANAN (SVP) sold 595 shares for an estimated $101,923
• LISA M. POOLE (VP and Controller) sold 350 shares for an estimated $60,126

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

KEYS Hedge Fund Activity

We have seen 360 institutional investors add shares of KEYS stock to their portfolio, and 376 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KOVITZ INVESTMENT GROUP PARTNERS, LLC added 3,650,953 shares (+364.6%) to their portfolio in Q4 2024, for an estimated $586,452,580
• PRICE T ROWE ASSOCIATES INC /MD/ added 3,621,349 shares (+29.0%) to their portfolio in Q4 2024, for an estimated $581,697,289
• BLACKROCK, INC. removed 1,880,483 shares (-10.7%) from their portfolio in Q4 2024, for an estimated $302,061,984
• VAN ECK ASSOCIATES CORP removed 1,219,887 shares (-88.4%) from their portfolio in Q4 2024, for an estimated $195,950,448
• JENNISON ASSOCIATES LLC removed 1,091,378 shares (-50.7%) from their portfolio in Q4 2024, for an estimated $175,308,048
• MILLENNIUM MANAGEMENT LLC added 960,708 shares (+976.2%) to their portfolio in Q4 2024, for an estimated $154,318,526
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 827,421 shares (-20.1%) from their portfolio in Q4 2024, for an estimated $132,908,635

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of HELIOGEN HOLDINGS INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

HLGN Insider Trading Activity

HLGN insiders have traded $HLGN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HLGN stock by insiders over the last 6 months:

• PHYLLIS W. NEWHOUSE sold 12,582 shares for an estimated $23,680

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HLGN Hedge Fund Activity

We have seen 1 institutional investors add shares of HLGN stock to their portfolio, and 1 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ANCORA ADVISORS LLC added 14,004 shares (+inf%) to their portfolio in Q4 2024, for an estimated $25,207
• MFA WEALTH ADVISORS, LLC removed 14 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $25
• HORIZON FINANCIAL SERVICES, LLC added 0 shares (+0.0%) to their portfolio in Q4 2024, for an estimated $0
• AVIOR WEALTH MANAGEMENT, LLC added 0 shares (+0.0%) to their portfolio in Q4 2024, for an estimated $0

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of FOX CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Retransmission consent. Online Privacy. Spectrum-related issues. Media ownership issues. First Amendment issues. Sports betting. Sports and event futures. Children's educational TV programming. Advertising issues. Copyright and content carriage issues. Section 230 of the Communications Decency Act. Antitrust enforcement and reform. Corporate tax issues."

You can find more data on corporate lobbying on Quiver Quantitative.

FOX Insider Trading Activity

FOX insiders have traded $FOX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $FOX stock by insiders over the last 6 months:

• KEITH RUPERT MURDOCH has made 0 purchases and 4 sales selling 1,115,895 shares for an estimated $51,447,113.
• JOHN NALLEN (Chief Operating Officer) sold 182,481 shares for an estimated $7,979,894
• ADAM G. CIONGOLI (Chief Legal and Policy Officer) has made 0 purchases and 2 sales selling 1,278 shares for an estimated $69,178.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FOX Hedge Fund Activity

We have seen 184 institutional investors add shares of FOX stock to their portfolio, and 154 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MIRABELLA FINANCIAL SERVICES LLP removed 1,226,347 shares (-99.4%) from their portfolio in Q4 2024, for an estimated $56,093,111
• ASSENAGON ASSET MANAGEMENT S.A. added 1,095,073 shares (+58.4%) to their portfolio in Q4 2024, for an estimated $50,088,639
• UBS GROUP AG added 1,073,980 shares (+46.8%) to their portfolio in Q4 2024, for an estimated $49,123,845
• WEDGE CAPITAL MANAGEMENT L L P/NC added 1,062,664 shares (+inf%) to their portfolio in Q4 2024, for an estimated $48,606,251
• YACKTMAN ASSET MANAGEMENT LP removed 796,792 shares (-10.0%) from their portfolio in Q4 2024, for an estimated $36,445,266
• INDEPENDENT FRANCHISE PARTNERS LLP added 759,874 shares (+15.4%) to their portfolio in Q4 2024, for an estimated $34,756,636
• AMUNDI added 702,561 shares (+83.0%) to their portfolio in Q4 2024, for an estimated $32,135,140

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$VZ stock has now risen 2% today, according to our price data from Polygon. There has been approximately $635,941,950 of trading volume.

$VZ Insider Trading Activity

$VZ insiders have traded $VZ stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $VZ stock by insiders over the last 6 months:

• KYLE MALADY (EVP and Group CEO-VZ Business) has made 0 purchases and 5 sales selling 65,675 shares for an estimated $2,654,457.
• VANDANA VENKATESH (EVP-PubPol&ChiefLegalOfficer) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $437,938.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$VZ Hedge Fund Activity

We have seen 1,201 institutional investors add shares of $VZ stock to their portfolio, and 1,499 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GQG PARTNERS LLC removed 12,391,586 shares (-50.1%) from their portfolio in Q4 2024, for an estimated $495,539,524
• MORGAN STANLEY removed 10,038,212 shares (-12.9%) from their portfolio in Q4 2024, for an estimated $401,428,097
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 9,485,571 shares (-45.7%) from their portfolio in Q4 2024, for an estimated $379,327,984
• LEGAL & GENERAL GROUP PLC removed 9,454,780 shares (-25.7%) from their portfolio in Q4 2024, for an estimated $378,096,652
• ALYESKA INVESTMENT GROUP, L.P. added 8,695,736 shares (+3601.6%) to their portfolio in Q4 2024, for an estimated $347,742,482
• CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 7,421,148 shares (+7.3%) to their portfolio in Q4 2024, for an estimated $296,771,708
• CAPITAL RESEARCH GLOBAL INVESTORS added 6,846,514 shares (+52.7%) to their portfolio in Q4 2024, for an estimated $273,792,094

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$VZ Government Contracts

We have seen $4,914 of award payments to $VZ over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• AID - DEDICATED INTERNET LINK 50MB: $4,914

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$VZ Congressional Stock Trading

Members of Congress have traded $VZ stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $VZ stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 01/15.
• REPRESENTATIVE EMILY RANDALL sold up to $15,000 on 01/06.
• SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$VZ Analyst Ratings

Wall Street analysts have issued reports on $VZ in the last several months. We have seen 2 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Tigress Financial issued a "Underperform" rating on 10/23/2024
• Cowen & Co. issued a "Buy" rating on 10/23/2024
• Goldman Sachs issued a "Buy" rating on 10/22/2024
• Scotiabank issued a "Underperform" rating on 10/18/2024
• Citigroup issued a "Underperform" rating on 10/14/2024

To track analyst ratings and price targets for $VZ, check out Quiver Quantitative's $VZ forecast page.

$VZ Price Targets

Multiple analysts have issued price targets for $VZ recently. We have seen 4 analysts offer price targets for $VZ in the last 6 months, with a median target of $49.0.

Here are some recent targets:

• John Hodulik from UBS set a target price of $44.0 on 10/23/2024
• Gregory Williams from Williams Trading set a target price of $51.0 on 10/23/2024
• Maher Yaghi from Scotiabank set a target price of $47.0 on 10/23/2024
• James Schneider from Goldman Sachs set a target price of $52.0 on 10/22/2024

You can track data on $VZ on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$JNJ stock has now risen 3% today, according to our price data from Polygon. There has been approximately $805,814,824 of trading volume.

$JNJ Insider Trading Activity

$JNJ insiders have traded $JNJ stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:

• JOSEPH J WOLK (Exec VP, CFO) sold 13,015 shares for an estimated $2,002,878
• ROBERT J DECKER (VP Corporate Controller) sold 6,999 shares for an estimated $1,160,994
• MARK A WEINBERGER purchased 1,000 shares for an estimated $147,220
• TIMOTHY SCHMID (EVP, WW Chair, MedTech) sold 403 shares for an estimated $62,928

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$JNJ Hedge Fund Activity

We have seen 1,427 institutional investors add shares of $JNJ stock to their portfolio, and 2,070 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ removed 8,877,281 shares (-35.3%) from their portfolio in Q4 2024, for an estimated $1,283,832,378
• JPMORGAN CHASE & CO added 4,985,149 shares (+14.7%) to their portfolio in Q4 2024, for an estimated $720,952,248
• PINNACLE ASSOCIATES LTD added 4,703,577 shares (+359.8%) to their portfolio in Q4 2024, for an estimated $680,231,305
• LEGAL & GENERAL GROUP PLC removed 4,603,436 shares (-19.9%) from their portfolio in Q4 2024, for an estimated $665,748,914
• JANUS HENDERSON GROUP PLC added 4,559,147 shares (+134.5%) to their portfolio in Q4 2024, for an estimated $659,343,839
• LAZARD ASSET MANAGEMENT LLC removed 3,705,273 shares (-85.3%) from their portfolio in Q4 2024, for an estimated $535,856,581
• NORTHERN TRUST CORP added 3,363,235 shares (+12.3%) to their portfolio in Q4 2024, for an estimated $486,391,045

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$JNJ Government Contracts

We have seen $44,417,325 of award payments to $JNJ over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• 4565676752!5.5MM TI CANN SCREW + ST - 65MM: $558,058
• 8510979866!OTHER MEDICAL: $399,070
• 4565921178!2.4MM VA-LCP DISTAL: $363,348
• 4565956035!CSS+ SMALL SET: $290,401
• 4564287529!3.5MM TI CANN SCREW + FT - 42MM: $276,497

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$JNJ Congressional Stock Trading

Members of Congress have traded $JNJ stock 18 times in the past 6 months. Of those trades, 15 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/24.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 6 times. They made 6 purchases worth up to $90,000 on 01/24, 01/21, 01/16, 12/12, 11/26, 11/22 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 5 times. They made 5 purchases worth up to $75,000 on 01/08, 12/24, 11/25 and 0 sales.
• REPRESENTATIVE KEVIN HERN sold up to $250,000 on 12/31.
• REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 12/10.
• REPRESENTATIVE VIRGINIA FOXX purchased up to $15,000 on 12/06.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 10/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$JNJ Analyst Ratings

Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 01/22/2025
• Cantor Fitzgerald issued a "Overweight" rating on 10/14/2024
• Cowen & Co. issued a "Buy" rating on 10/14/2024
• RBC Capital issued a "Buy" rating on 10/10/2024

To track analyst ratings and price targets for $JNJ, check out Quiver Quantitative's $JNJ forecast page.

$JNJ Price Targets

Multiple analysts have issued price targets for $JNJ recently. We have seen 9 analysts offer price targets for $JNJ in the last 6 months, with a median target of $175.0.

Here are some recent targets:

• Vamil Divan from Guggenheim set a target price of $166.0 on 02/03/2025
• Chris Shibutani from Goldman Sachs set a target price of $159.0 on 10/16/2024
• Terence Flynn from Morgan Stanley set a target price of $175.0 on 10/16/2024
• Shagun Singh from RBC Capital set a target price of $181.0 on 10/16/2024
• Joanne Wuensch from Citigroup set a target price of $185.0 on 10/16/2024
• Larry Biegelsen from Wells Fargo set a target price of $166.0 on 10/15/2024
• Rick Wise from Stifel Nicolaus set a target price of $170.0 on 10/15/2024

You can track data on $JNJ on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$NEE stock has now risen 2% today, according to our price data from Polygon. There has been approximately $353,667,339 of trading volume.

$NEE Insider Trading Activity

$NEE insiders have traded $NEE stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $NEE stock by insiders over the last 6 months:

• NICOLE J DAGGS (EVP, Human Res & Corp Svcs) sold 4,007 shares for an estimated $302,808
• JAMES MICHAEL MAY (VP, Controller and CAO) sold 2,383 shares for an estimated $162,258

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NEE Hedge Fund Activity

We have seen 1,192 institutional investors add shares of $NEE stock to their portfolio, and 1,175 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 7,440,014 shares (-46.8%) from their portfolio in Q4 2024, for an estimated $533,374,603
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 6,189,259 shares (-35.9%) from their portfolio in Q4 2024, for an estimated $443,707,977
• GOLDMAN SACHS GROUP INC added 5,865,464 shares (+41.8%) to their portfolio in Q4 2024, for an estimated $420,495,114
• BLACKROCK, INC. added 5,447,115 shares (+3.5%) to their portfolio in Q4 2024, for an estimated $390,503,674
• FMR LLC removed 4,549,986 shares (-16.2%) from their portfolio in Q4 2024, for an estimated $326,188,496
• D. E. SHAW & CO., INC. added 4,345,741 shares (+246.7%) to their portfolio in Q4 2024, for an estimated $311,546,172
• LEGAL & GENERAL GROUP PLC removed 4,013,153 shares (-20.4%) from their portfolio in Q4 2024, for an estimated $287,702,938

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$NEE Government Contracts

We have seen $32,943,278 of award payments to $NEE over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• ELECTRICITY SUPPLY & ANCILLARY SERVICES FOR JSC (JSC, EF, SCTF): $7,980,066
• FY25 - RETAIL ELECTRIC CONTRACT (1 OCT 2024 - 30 SEP 2025) - GEXA ENERGY, LP: $6,615,000
• PROVIDE ELECTRIC SERVICES FOR E CABELL FOB-PO-CTHSE, 1100 COMMERCE ST, DALLAS, TX0284DA: $3,140,332
• CY 2025 ELECTRIC UTILITY SERVICES FOR GOODFELLOW AFB, TX: $2,666,000
• PROVIDE ELECTRIC SERVICES FOR 1 JUSTICE PARK DRIVE FED BLDG, 1 JUSTICE PARK, HOUSTON, TX. GSA BUILDING NO....: $1,505,718

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$NEE Congressional Stock Trading

Members of Congress have traded $NEE stock 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $NEE stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 01/21, 11/25, 11/07 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 01/15.
• REPRESENTATIVE GREG LANDSMAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$NEE Analyst Ratings

Wall Street analysts have issued reports on $NEE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 10/24/2024
• Seaport Global issued a "Sell" rating on 10/22/2024
• BMO Capital issued a "Outperform" rating on 10/18/2024

To track analyst ratings and price targets for $NEE, check out Quiver Quantitative's $NEE forecast page.

You can track data on $NEE on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$LW stock has now risen 7% today, according to our price data from Polygon. There has been approximately $236,441,233 of trading volume.

$LW Insider Trading Activity

$LW insiders have traded $LW stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $LW stock by insiders over the last 6 months:

• WILLIAM G JURGENSEN purchased 5,000 shares for an estimated $316,349
• ROBERT A NIBLOCK purchased 3,000 shares for an estimated $182,818
• CHARLES A BLIXT purchased 1,200 shares for an estimated $75,900

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LW Hedge Fund Activity

We have seen 288 institutional investors add shares of $LW stock to their portfolio, and 347 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS added 6,333,538 shares (+inf%) to their portfolio in Q4 2024, for an estimated $423,270,344
• JANA PARTNERS MANAGEMENT, LP added 3,604,585 shares (+102.2%) to their portfolio in Q4 2024, for an estimated $240,894,415
• FMR LLC removed 2,815,549 shares (-28.9%) from their portfolio in Q4 2024, for an estimated $188,163,139
• UBS GROUP AG added 2,407,382 shares (+367.9%) to their portfolio in Q4 2024, for an estimated $160,885,339
• HARRIS ASSOCIATES L P removed 1,251,674 shares (-93.0%) from their portfolio in Q4 2024, for an estimated $83,649,373
• INTERVAL PARTNERS, LP added 1,199,918 shares (+inf%) to their portfolio in Q4 2024, for an estimated $80,190,519
• 1832 ASSET MANAGEMENT L.P. removed 1,147,100 shares (-81.9%) from their portfolio in Q4 2024, for an estimated $76,660,693

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$LW Congressional Stock Trading

Members of Congress have traded $LW stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $LW stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 01/15.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.
• SENATOR GARY C. PETERS sold up to $15,000 on 10/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$LW Analyst Ratings

Wall Street analysts have issued reports on $LW in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 10/21/2024

To track analyst ratings and price targets for $LW, check out Quiver Quantitative's $LW forecast page.

$LW Price Targets

Multiple analysts have issued price targets for $LW recently. We have seen 3 analysts offer price targets for $LW in the last 6 months, with a median target of $87.0.

Here are some recent targets:

• Thomas Palmer from Coker Palmer set a target price of $90.0 on 10/21/2024
• Peter Galbo from Bank of America Securities set a target price of $80.0 on 10/21/2024
• Andrew Lazar from Barclays set a target price of $87.0 on 10/18/2024

You can track data on $LW on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$CNC stock has now risen 4% today, according to our price data from Polygon. There has been approximately $118,374,914 of trading volume.

$CNC Insider Trading Activity

$CNC insiders have traded $CNC stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CNC stock by insiders over the last 6 months:

• THOMAS GRECO purchased 17,000 shares for an estimated $1,015,750
• ANDREW LYNN ASHER (Chief Financial Officer) purchased 17,200 shares for an estimated $1,000,008
• CHRISTOPHER J COUGHLIN purchased 10,000 shares for an estimated $594,400
• THEODORE R. II SAMUELS purchased 5,000 shares for an estimated $294,300
• SARAH LONDON (Chief Executive Officer) purchased 4,117 shares for an estimated $250,313
• H JAMES DALLAS purchased 1,693 shares for an estimated $99,903
• JESSICA L. BLUME purchased 250 shares for an estimated $14,870

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CNC Hedge Fund Activity

We have seen 360 institutional investors add shares of $CNC stock to their portfolio, and 469 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BOSTON PARTNERS removed 7,624,593 shares (-83.3%) from their portfolio in Q4 2024, for an estimated $461,897,843
• CAPITAL WORLD INVESTORS removed 5,061,954 shares (-22.4%) from their portfolio in Q4 2024, for an estimated $306,653,173
• NORGES BANK added 4,145,338 shares (+19.5%) to their portfolio in Q4 2024, for an estimated $251,124,576
• MILLENNIUM MANAGEMENT LLC added 4,113,280 shares (+204.2%) to their portfolio in Q4 2024, for an estimated $249,182,502
• JPMORGAN CHASE & CO removed 3,915,351 shares (-71.3%) from their portfolio in Q4 2024, for an estimated $237,191,963
• SWEDBANK AB removed 3,703,205 shares (-68.6%) from their portfolio in Q4 2024, for an estimated $224,340,158
• POLITAN CAPITAL MANAGEMENT LP removed 3,362,610 shares (-27.7%) from their portfolio in Q4 2024, for an estimated $203,706,913

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CNC Analyst Ratings

Wall Street analysts have issued reports on $CNC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 10/29/2024

To track analyst ratings and price targets for $CNC, check out Quiver Quantitative's $CNC forecast page.

You can track data on $CNC on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.